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 The mitochondrial intermembrane space (IMS) is a unique subcellular 
compartment that houses key thiol-dependent redox pathways such as protein transport, 
mitochondrial respiration, and detoxification of ROS (reactive oxygen species). These 
pathways are all dependent on cysteine-rich proteins, thus maintaining thiol-disulfide 
balance in this organelle is crucial for cellular functions. An IMS protein import pathway 
called the Mia40-Erv1 disulfide relay system uses disulfide bond formation for the import 
and retention of substrate proteins in the IMS. Erv1 is also suggested to be involved in 
maturation of cytosolic Fe-S cluster proteins and regulation of iron homeostasis in S. 
cerevisiae. However, these studies were performed on one particular erv1 mutant strain 
(named as erv1-1) that we discovered has additional defects in glutathione (GSH) 
metabolism due to a secondary mutation in the gene encoding the GSH biosynthesis 
enzyme, Gsh1. Since the tripeptide GSH is also required for iron homeostasis and 
cytosolic Fe-S protein biogenesis, the Erv1-dependent connection between mitochondrial 
protein import, GSH metabolism, and iron homeostasis was investigated in several erv1 
mutants. The GSH depletion phenotype was only detected in the erv1-1 strain and could 
be rescued by expressing GSH1 or adding GSH to the growth media. Additionally, 
expression of the iron uptake gene, FET3 and enzyme activities of Fe-S cluster proteins 
in several erv1 mutants were tested. Only the erv1-1 mutant has an iron misregulation 
defect, which could be rescued with GSH addition, and no significant effects on Fe-S 
cluster protein activities were detected. Our data suggests that the defects of cytosolic Fe-
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S maturation and iron regulation first reported in the erv1-1 strain is a direct consequence 
of GSH depletion rather than indicating a direct role for Erv1 in iron metabolism and 
cytosolic Fe-S cluster biogenesis. 
We also characterized how mutations of Mia40 influence GSH metabolism and 
GSH:GSSG pools in the cytosol, mitochondrial matrix and intermembrane space. We 
have found that defects in Mia40 only influence the IMS redox state and do not alter 
cellular GSH levels. Additionally, we determined that defects in Mia40 do not impact 
iron homeostasis or Fe-S cluster biogenesis.   
Furthermore, utilizing the roGFP2 in vivo sensors, we demonstrated how the 
deletion of manganese cofactor of superoxide dismutase 2 transporter Mtm1 and the 
citrate-oxoglutarate carrier Yhm2 affect the redox status of the mitochondrial matrix and 
IMS and cellular GSH levels. Deletion of MTM1 only leads to a large oxidative shift in 
the IMS GSH:GSSG redox state. In the contrary, deletion of YHM2 shows a smaller 
effect on the mitochondrial GSH:GSSG redox state even though, both mtm1∆ and yhm2∆ 
mutants were shown to have reduced mitochondrial GSH levels. Overall, we successfully 
characterized the roles of Erv1 and Mia40 in GSH metabolism, mitochondrial import and 
subcellular redox state which hereby helps to reveal their roles in Fe-S cluster biogenesis 
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Cellular distribution of thiol redox systems in Saccharomyces cerevisiae. Thiol-
disulfide homeostasis is critical for eukaryotic cells since the redox state of redox-active 
cysteine residues influences the structure and the function of enzymes, transcriptional 
factors and receptors. In addition, thiol-disulfide balance is regulated by reactive oxygen 
species (ROS) and unbalanced production of ROS can lead to damage to DNA, proteins, 
and lipids.  In order to protect themselves against oxidative damage, cells have developed 
a series of response systems to maintain thiol-disulfide redox homeostasis. These defense 
systems include antioxidant enzymes and free radical scavengers. Two primary anti-
oxidant systems, glutathione/glutaredoxin (GRX) and thioredoxin (TRX) systems are 
universally conserved thiol-reductase systems. Thioredoxin and glutathione pathways in 
the model eukaryote Saccharomyces cerevisiae are indispensable for survival. Both 
pathways exist in the cytosol of Saccharomyces cerevisiae, of which the thioredoxin 
pathway has the primary dominant thiol redox function, while the glutathione pathway 
functions as back up of the former (Kumar C et al 2011). The mitochondrial matrix 
possesses thioredoxin and glutathione pathways in which the glutathione pathway rules 
over the thioredoxin pathway. In addition, the endoplasmic reticulum (ER) and 
mitochondrial intermembrane space (IMS) harbor essential thiol oxidation reactions. 
Unlike the IMS, the ER lacks thiol reductase pathways except glutathione but the IMS 
houses glutaredoxin 1/2 as a reducing pathway (Kojer K et al 2015). 
The cytosolic thiol redox system in the cytosol of S. cerevisiae is composed of 
two thioredoxin isoforms (Trx1 and Trx2) and a thioredoxin reductase (Trr1) (Toledano 
MB et al 2003) and two dithiol glutaredoxins Grx1 and Grx2 (Luikenhuis S et al 1998) 
and a glutathione reductase Glr1 (Collinson LP et al 1995). TRXs are thiol 
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oxidoreductases and reduce disulfide bonds by thiol-disulfide exchange reactions via two 
conserved cysteine residues at the active site. Oxidized thioredoxin is reduced to the 
active thiol form by NADPH-dependent thioredoxin reductase (Figure 1.1-A) (Holmgren 
A 1989). TRXs are required for the numerous pathways, including reduction of 
ribonucleotide reductase (RNR), which is essential for producing dNTP pools for DNA 
synthesis (Camier S et al 2007), for reduction of 3’-phosphoadenylsulfate (PAPS) 
reductase participating in inorganic sulfate assimilation (Muller EG 1991), or for 
thioredoxin peroxides. Moreover, thioredoxins reduce cytosolic peroxiredoxins Tsa1, 
Tsa2, and Ahp1, glutathione peroxidase-like enzymes Gpx1, Gpx2, and Gpx3 which are 
crucial to detoxify of hydrogen peroxide, and methionine sulfoxide reductases Mrx1 and 
Mrx2. Thioredoxins also negatively regulate the peroxide-stress regulator Yap1 by 
reduction (Carmel-Harel O et al 2001) and activates the general stress regulators Msn2/4 
in response to hydrogen peroxide (H2O2) (Boisnard S et al 2009). Generally, thioredoxins 
are important for controlling the redox state of protein sulfhydryls, especially in 
antioxidant proteins.  
In addition to TRXs, the yeast glutathione pathway is another major thiol redox 
system in the cytosol. Similar to TRXs, glutaredoxins (GRXs) are small thiol 
oxidoreductases required for the reduction of protein disulfides or glutathione-protein 
mixed disulfides. Glutathione (GSH) acts as a hydrogen donor by reducing oxidized 
glutaredoxin, and glutathione reductase (Glr1) provides electrons from NADPH to 
regenerate GSH from glutathione disulfide (GSSG) (Figure 1.1-A) (Toledano MB et al 








Figure 1.1 GSH-Glutaredoxin and Thioredoxin systems in the cytosol. A) Yeast 
possesses cytoplasmic glutaredoxins (GRX1 and GRX2) and thioredoxins (TRX1 
TRX2). The oxidized disulfide form of thioredoxin is reduced by thioredoxin 
reductase (Trr1) and NADPH. GSH reduces oxidized GRX and GSSG, in turn, is 
reduced by GSSG reductase (Glr1) in an NADPH-dependent manner. In addition, 
TRX systems (Trx1, Trx2 and Trr1) can reduce oxidized GSSG (Morgan B et al 2013 
and Tan SX et al 2010). B) GSH-GRX and TRX systems in the mitochondrial matrix. 
Yeast also includes a mitochondrial TRX system consisting of TRX3 and a 
thioredoxin reductase (TRR2). Grx2 and Glr1 co-localize to the cytosol and 
mitochondrial matrix. Adapted from ref. (Trotter EW et al 2005). 
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Cells lacking GSH are inviable both aerobically and anaerobically without exogenously 
added GSH, while ∆grx1∆grx2 and ∆glr1 cells are viable. Thus, GSH has functions not 
shared with other pathways. The reason of the requirement of GSH for viability is 
confusing since this requirement is not related to oxidative stress, or to inadequate DNA 
synthesis or defective reduction of the essential RNR disulfide. In addition, alternative 
thiol-reducing agents such as cysteine, DTT or N-acetyl cysteine (NAC) do not rescue 
GSH auxotrophy of the ∆gsh1 mutant (Lee JC et al 2001). Kumar C et al showed that 
GSH depletion and toxic levels of GSH conditions using the ∆gsh1 and HGT1-
overexpressing strains resulted in major changes in iron metabolism, but did not 
significantly affect thiol-redox control. This study demonstrated that the essential role of 
GSH is related to its function in iron metabolism, which requires minute amounts of the 
tripeptide, whereas its thiol-redox function only performs as a backup of the TRX system 
which requires high levels of the tripeptide (Kumar C et al 2011). RNR reduction is an 
important target for thiol redox control carried out by the TRX pathway since RNR 
provides the dNTPs essential for DNA synthesis and repair. However, ∆trx1∆trx2 
knockout cells are viable which indicates that the GSH pathway can back up the TRX 
pathway. The lethality arising from the several deletions of both pathways such as 
∆glr1∆trx1∆trx2, ∆trx1∆trx2∆grx1∆grx2, ∆glr1∆trr1, ∆gsh1∆trx1∆trx2, or ∆gsh1∆trr1 
might be result from deficient RNR reduction (Trotter EW et al 2003 and Draculic T et al 
2000). This observation also favors GSH acting as a backup system in RNR reduction in 
the absence of TRXs. Another clue of incapacity of GSH pathway is redox control of 
phosphoadenylyl-sulfate reductase (PAPS reductase) (Muller EG 1994). Grx1 and Grx2 
could replace thioredoxins in PAPS reduction only when low aeration is present since 
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∆trx1∆trx2 cells are able to grow on sulfate-containing media under the decreased 
reactive oxygen species conditions (Draculic T et al 2000). Cells depleted of GSSG 
reductase (Glr1) are viable, indicating that accumulated GSSG in the ∆glr1 strain is not 
deleterious or stored in any subcellular compartment (Collinson et al 1995). With regard 
to this, a recent study demonstrated that the ATP-binding cassette-C (ABC-C) 
transporter, Ycf1 (yeast cadmium factor), mediates removal of cytosolic GSSG that is not 
immediately reduced in the cytosol via transport into the vacuole. This study also showed 
that cytosolic GSH:GSSG homeostasis is strictly regulated and remains in the reduced 
state after the deletion of GLR1 (the major GSSG reductive system) or treatment with 
H2O2 and is completely independent of changes in whole-cell GSSG. Furthermore, Trx2 
and Grx2 were identified as backup systems to GSSG reductase for cytosolic GSSG 
reduction (Morgan B et al 2013). Consistent with these observations, it was shown that 
the TRX/TRX reductase system (Trx1, Trx2, and Trr1) can function as an alternate 
GSSG reducing system (Figure 1.1-A) (Tan SX et al 2010).  
Saccharomyces cerevisiae possesses two dithiol GRXs, Grx1 and Grx2. Both of 
them are present at the cytosol and a fraction of Grx2 is also located in mitochondria. 
Grx1 and Grx2 protect cells against the superoxide anion and hydroperoxides 
(Luikenhuis et al 1998). Their protective role might be explained by the fact that they are 
active in vitro as glutathione-S-transferases (GSTs) and they show peroxidase and GST 
activities in the presence of GSH in vitro (Collinson EJ et al 2002). Yeast cells have two 
GSTs (Gtt1 and Gtt2) and Grx1/2 can function cooperatively with both GSTs to protect 
against hydroperoxides and toxic xenobiotics (Collinson EJ et al 2002).  
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In conclusion, the TRX pathway has the major role in cytosolic thiol redox 
control in Saccharomyces cerevisiae. In contrast, the GRX/GSH pathway has only a 
limited role which serves as a backup system in the absence of the TRX pathway or in the 
presence of severe redox stresses (Kumar C et al 2011). In contrast to their E. coli 
partners, these pathways cooperate with each other to achieve thiol-redox homeostasis in 
the cell.  
The yeast mitochondrial matrix has a complete TRX pathway consisting of a TRX 
(Trx3) and a TRX reductase (Trr2) and GRX/GSH pathway consisting of GSSG 
reductase (Glr1) and dithiol GRX (Grx2) which are not functionally separated as 
observed in their cytosolic partners (Figure 1.1-B). In addition, the yeast matrix has its 
own NADPH source produced by the NADH kinase Pos5 (Outten CE et al 2003). The 
known function of the mitochondrial TRX and GRX/GSH pathways is to reduce 
respiratory and exogenous ROS through Prx1, which is a mitochondrial peroxiredoxin 
with TRX peroxidase activity and through possibly also GSH peroxidase 2 (Gpx2) 
(Perkins A et al 2014). Furthermore, the mitochondrial matrix redox homeostasis is 
maintained separately and isolated from redox changes from the other cell compartments 
In addition, using Grx1-roGFP2 sensors, J. Riemer and coworkers showed that the inner 
mitochondrial membrane (IMM) prevents the equilibration of GSH:GSSG pools in the 
matrix and IMS in vivo and in vitro (Riemer J et al 2012). Nonetheless, the matrix has to 
import GSH or GSSG from the cytosol to replenish its GSH:GSSG pool but the import 
mechanism is still unknown. The mitochondrial matrix also harbors a monothiol GRX 
Grx5. It is not known to have a function in redox homeostasis but it is involved in Fe-S 
cluster biosynthesis (Rodriguez MT et al 2002).  
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In vivo genetically encoded redox sensors.  As in vivo, assessing the subcellular redox 
state of GSH:GSSG pools in different compartments is crucial since different cell 
organelles have distinct redox environments because of their unique functions. 
Østergaard and coworkers have engineered a genetically-encoded, cytosolic redox sensor 
based on the yellow variant of green fluorescent protein (GFP) called redox-sensitive 
YFP (rxYFP) which is used for intracellular redox state measurements (Ostergaard H et 
al 2004). GFP and its derivatives are ideal in vivo sensors because of their protease 
resistance and high stability under the different range of pH and buffer conditions (Cubitt 
AB et al 1995). Measurement of the intracellular redox state by rxYFP in cells is 
performed via generation of an engineered disulfide bond that perturbs the local 
chromophore environment without significantly changing the overall β-can fold 
(Ostergaard H et al 2001). The relative ratio of oxidized to reduced rxYFP can be easily 
determined via non-reducing SDS-PAGE in which the two protein forms show different 
electrophoretic mobilities. In addition, Østergaard and coworkers have demonstrated both 
in vivo and in vitro that the cysteines in rxYFP specifically equilibrate with GSH and 
GSSG via rapid disulfide exchange reactions with the cytosolic glutaredoxins (GRXs) 
(Ostergaard H et al 2004). Another redox-sensitive fluorescent probe is roGFP2 
developed by inserting an artificial dithiol-disulfide pair into GFP with two cysteines at 
sites 147 and 202.  Oxidation causes an increase in the 400 nm excitation peak and a 
decrease in the 475 nm peak for roGFP2. roGFP2 is more advantageous over rxYFP 
since it is a ratiometric sensor and therefore does not include errors obtained from 
variations in light intensity, sensor concentration and photobleaching problems (Hanson 
et al 2004 and Dooley et al 2004). roGFP2 was also fused with human glutaredoxin-1 
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(Grx1) creating Grx1-roGFP2. Recently Grx1-roGFP2 became more widely used than the 
rxYFP because Grx1-roGFP2 facilitates rapid equilibration between the sensor protein 
and the GSH/GSSG redox couple (Gutscher M et al 2008).  
GSH, Erv1-Mia40 IMS disulfide relay system and other redox control systems in the 
mitochondrial IMS. Mitochondria consist of two compartments, the matrix and the 
intermembrane space. Most mitochondrial proteins are nuclear-encoded and synthesized 
in the cytosol. They are imported into mitochondria as precursors with a mitochondrial 
targeting signal (MTS) or internal targeting sequences (ITS). The import of matrix-
targeted proteins is carried out by the outer membrane translocase (TOM complex) and 
inner membrane translocase (TIM23 complex) in an ATP and membrane potential-
dependent manner (Herrmann JM et al 2012). The mitochondrial IMS is a small 
subcellular compartment that houses several proteins and proteins in the IMS show 
distinct functions. A recently published yeast proteome study identified ~50 different 
IMS proteins (Vögtle FN et al 2012). Several apoptotic components are stored in the IMS 
and they are released into the cytosol when cell death program is triggered (Martinou JC 
et al 2011). In addition, IMS proteins are involved in the detoxification of ROS (reactive 
oxygen species) (Godon C et al 1998), mitochondrial respiration (Smith PM et al 2012), 
and transporting of proteins, metabolites, lipids and metal ions between mitochondrial 
membranes (Leary SC et al 2007 and Osman C et al 2009). IMS proteins are synthesized 
by cytosolic ribosomes similar to matrix proteins but only a few of them possess bipartite 
presequences including an N-terminal MTS and a hydrophobic sorting region. IMS 
proteins lacking N-terminal targeting signals are usually smaller than 20 kDa and their 
proper folding in the IMS prevents their translocation to the cytosol (Petrungaro C et al 
10 
 
2014). Folding of some of those proteins can be initiated by the binding of a cofactor. For 
instance, folding and retention of cytochrome c in the IMS depends on heme cofactor 
binding (Dumont ME et al 1988).  
An IMS protein import pathway called the Mia40-Erv1 disulfide relay system 
uses disulfide bond formation for the import and retention of proteins in the IMS (Sideris 
DP et al 2010 and Riemer J et al 2011). The substrate proteins of this machinery pass the 
outer membrane through the TOM complex in an unfolded and reduced state. Most of the 
substrates of this pathway possess twin CX3C or twin CX9C motifs (C, cysteine; X, any 
amino acid). They have a common structure in which cysteine motifs are aligned in two 
antiparallel helices constituting a helix-loop-helix motif. These substrate proteins are 
maintained in the reduced state in the cytosol by cytosolic GRXs in human cells and the 
TRX system in yeast (Banci L et al 2013 and Durigon R et al 2012). In addition, the 
cytosolic proteasome system controls the degradation of newly synthesized substrate 
proteins of the Mia40-Erv1 import pathway before they are imported (Bragoszewski P et 
al 2013). Newly imported substrate proteins become oxidized by the oxidoreductase, 
import receptor, and chaperone Mia40 (mitochondrial IMS import and assembly) and 
Mia40 becomes reduced. The N-terminal domain of the sulfhydryl oxidase Erv1 
(Essential for Respiration and Viability) reoxidizes reduced Mia40, which forms reduced 
Erv1. Electrons are then transported to cytochrome c via the FAD domain of Erv1, which 
additionally transfers the electrons through cytochrome c oxidase to the final electron 












































































Figure 1.2 Erv1-Mia40 import pathway and GRX redox systems in the IMS. 
Substrates of this import pathway are synthesized in the cytosol and are kept in the 
reduced state by the local GSH:GSSG pool and GRXs in humans and TRXs in yeast. 
The cytosolic proteasome regulates the degradation of substrate proteins. The 
cytosolic GSH:GSSG pool is connected to the IMS GSH:GSSG pool by porins in the 
outer mitochondrial membrane. Limiting amounts of the IMS-localized Grx1 and 2 
impedes the full equilibration of Mia40 with the local GSH:GSSG pool. 
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The oxidoreductase Mia40 possesses a helix-loop-helix domain that is conserved 
in all Mia40 homologs. This domain contains six cysteine residues present in the pattern 
CPC-..-CX9C-..CX9C and is stabilized by two parallel structural disulfide bonds. The 
redox active CPC motif is positioned in a short helix and connected to a helix-loop-helix 
region that includes the twin CX9C motif. The CPC motif has to be in an oxidized state to 
oxidize incoming substrates. The two long helices constitute a hydrophobic binding 
groove in which substrate proteins containing a MISS signal (mitochondrial IMS-sorting 
signal or ITS for IMS-targeting signal) are able to bind (Herrmann JM and Riemer J 
2012). 
The sulfhydryl oxidase Erv1 was initially found to serve as a compound that 
stimulates liver regeneration and in mammalian cells is referred to as augmenter of liver 
regeneration (ALR), growth factor Erv1-like (Gfer1) or hepatopoietin (Hagiya M et al 
1994). Erv1 is a homodimeric flavoprotein in which each subunit is composed of two 
domains. The N-terminal shuttle domain containing a redox-active CXXC motif forms an 
intermolecular disulfide with Mia40 during reoxidation of Mia40 and shuttles electrons to 
the CXXC motif in the C-terminal (FAD) domain of Erv1. The C-terminal FAD-binding 
domain shuttles electrons via the FAD cofactor to cytochrome c, which channels 
electrons to the cytochrome c oxidase complex. Additionally, Erv1 includes a structural 
disulfide bond stabilizing the four-helix bundle structure (Guo P et al 2012) (Figure 1.3). 
Another factor facilitating oxidative folding is Hot13, a small cysteine-rich IMS protein. 
Hot13 is able to chelate zinc ions from reduced Mia40, which improves the reoxidation 
of Mia40 by Erv1, thereby accelerating mitochondrial import (Curran SP et al 2004 and 











Figure 1.3 Erv1 C-Terminal Core Domain Structure which is from Asp86 to 
Asp188. A) The active sites are shown with ball and stick models, and the bound FAD 
molecules are shown as green sticks. The core redox center (Cys130–Cys133) is in 
proximity to the isoalloxazine ring of FAD. B) Hydrophobic residues at the dimeric 
interface are shown as sticks. Phe124 is at the center of the dimeric interface of Erv1 
protein. Reproduced with permission from (Guo P et al 2012). 
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 In addition to Mia40/Erv1, there are other factors influencing the disulfide relay 
system in the IMS: the local GSH:GSSG pool and Grx1 and 2 (Kojer K et al 2012, Bien 
MLS et al 2010 and Kojer K et al 2015). By the use of rxYFP probes, our lab showed that 
the redox state of the IMS is maintained separately and considerably more oxidizing than 
the cytosol and matrix (Hu J et al 2008). However, by the use of GRX-fused redox-
sensitive fluorescence proteins (Grx1-roGFP2), it was suggested that IMS GSH:GSSG 
pools equilibrate with the cytosol , resulting in a reducing redox state in the IMS. 
Moreover, this study showed that the IMS GSH:GSSG pool  is dependent upon cytosolic 
GSSG reductase (GLR) activity, cytosolic NADPH generation and porins in the OMM 
(outer mitochondrial membrane) (Kojer K et al 2012). In addition, the cytosolic GSSG 
reductase affects the Mia40 redox state in intact wild-type cells. In terms of this study, 
the Mia40 redox state is balanced between Erv1 with oxidizing impact and GSH:GSSG 
and substrates with reducing impact and appears to be in a semioxidized state (Kojer K et 
al 2012).  
 In in vitro studies, during the substrate oxidation, GSH serves in a vital 
proofreading role by hindering or removing long-lived complexes between Mia40 and its 
substrates to ensure sufficient substrate oxidation. These accumulated intermediates are 
likely composed of non-natively semioxidized substrates and stable off-pathway 
intermediates that prevent Mia40 from becoming oxidized and postpone substrate 
oxidation. Previously, it was shown that GSH concentrations at physiological levels 
stimulate the Erv1-Mia40 import pathway. Addition of GSH frees Mia40 from trapped 
complexes and leads to acceleration of protein import into the IMS (Bien MLS et al 
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2010). However, it is still unclear how the GSH:GSSG pool influences the Mia40 redox 
state and the Erv1-Mia40 oxidative folding pathway in IMS in vivo. 
 A recently published study showed the presence of GRXs (Grx1 and Grx2), 
predominantly Grx2, in the IMS and proposed that limiting amounts of these GRXs 
provide kinetic control to hamper reduction of Mia40 substrates by local GSH:GSSG 
pool (Figure 2). Overexpression of an IMS-targeted Grx2 variant leads to Mia40 
becoming more reduced and grx deletion prevents Mia40 reduction by GSH. 
Furthermore, overexpression of Grx2 results in delay in oxidative folding for Mia40 
substrates whose IMS import relies on oxidation by Mia40 (Kojer K et al 2015). 
Fe-S biogenesis, iron homeostasis and their link with Erv1 and GSH. Fe-S proteins 
perform diverse functions in mitochondria, cytosol and nucleus. They function in energy 
production (e.g. aconitase in the TCA cycle), electron transfer in respiratory chain 
complexes I and III, fatty acid oxidation, and lipoate and biotin biosynthesis in 
mitochondria. In the cytosol, they are involved in the amino acid synthesis 
(isopropylmalate isomerase), tRNA modification, post-transcriptional regulation of iron 
metabolism (IRP1) or regulation of ribosomal translation (ABC protein Rli1). Fe-S 
clusters are also crucial for nuclear proteins such as DNA polymerases and DNA 
helicases. Overall, mitochondrial Fe-S biogenesis plays a significant role in nuclear DNA 
maintenance, protein synthesis, translation, and nucleotide metabolism (Stehling O et al 
2013). 
 The maturation of cytosolic and nuclear Fe-S proteins in eukaryotic cells depends 
on the function of the mitochondrial iron-sulfur cluster (ISC) assembly machinery. This 
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process is assisted by the cytosolic Fe-S protein assembly (CIA) machinery and the ISC 
export machinery. The mitochondrial ISC assembly system produces a sulfur-containing 
compound that is exported to the cytosol for biogenesis of Fe-S cluster proteins in the 
cytosol and nucleus.  
 The ISC assembly and export systems are highly conserved from yeast to humans 
and eukaryotic cells are not viable without these proteins. Several disorders are 
associated with mutations in mitochondrial ISC assembly proteins and many of these 
diseases are fatal in humans. One of these Fe-S diseases is the neurodegenerative disorder 
Friedreich’s ataxia in which mutations have been found in the gene frataxin, FXN 
(homologue of yeast Yfh1) which is one of the core proteins of the ISC assembly 
pathway (Schmucker S et al 2010). As a result of decreased frataxin protein levels, 
impaired respiratory complexes I-III and mitochondrial aconitase activities were 
observed. In addition, defects in frataxin cause impaired cytosolic IRP1 maturation and 
mitochondrial iron accumulation. Another Fe-S protein whose mutation results in a 
clinical phenotype is mitochondrial GLRX5 (Grx5 in yeast). Mutation in GLRX5 leads to 
sideroblastic anemia characterized by mitochondrial iron accumulation (Camaschella et 
al 2007). Similarly, defects in the ISC assembly scaffold protein ISCU cause a myopathy 
with exercise intolerance because of impairments in mitochondrial and cytosolic Fe-S 
protein maturation and altered iron homeostasis (Mochel F et al 2008 and Crooks DR et 
al 2012). 
 The biogenesis of extramitochondrial Fe-S proteins consists of three steps. First of 
all, in mitochondria, [2Fe-2S] cluster is synthesized on the scaffold protein Isu1 and this 
process requires the cysteine desulfurase complex Nfs1–Isd11 (Muhlenhoff U et al 2003 
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and Pandey A et al 2013). In addition, this reaction utilizes frataxin for sulfur transfer and 
iron supply, and NADPH-ferredoxin reductase–ferredoxin redox chain for sulfur 
reduction to sulfide (Parent A et al 2015 and Webert H et al 2014). Fe-S cluster is then 
released from the scaffold protein Isu1 by the Hsp70-Hsp40 chaperone system, followed 
by Fe-S cluster transfer to Grx5 in a GSH-dependent manner. These ISC components 
constitute the core ISC system. The final biogenesis step includes the transfer of a [4Fe-
4S] cluster by ISC-targeting factors Isa1-Isa2 and Iba57 to specific apoproteins and 
insertion into the polypeptide chains by Nfu1 and Ind1 (Netz DJ et al 2014). 
 It is well known that Fe-S protein biogenesis regulates cellular iron metabolism. 
The mitochondrial ISC system has a major role in iron metabolism since depletion of the 
ISC assembly core proteins or components of the export system such as GSH/Erv1 or 
Atm1 is related to increased iron uptake and iron accumulation in mitochondria. In yeast, 
under iron-deficient conditions, iron regulation is controlled by the low iron-sensing 
transcriptional factor Aft1 and Aft2. Under the Fe-replete conditions, iron homeostasis is 
regulated by the transcriptional activator Yap5 (Outten CE et al 2013). In human cells, 
the major regulatory factors that influence cellular iron supply and distribution are iron 
regulatory proteins (IRP1) and (IRP2) via several post-transcriptional mechanisms 
(Anderson CP et al 2012). 
 As mentioned above, the core mitochondrial ISC proteins generate a sulfur-
containing compound required for maturation of cytosolic and nuclear Fe/S clusters 
(Kispal G et al 1999 and Gerber J et al 2004). It was proposed that the ISC export system 
includes the ATP binding cassette (ABC) transporter (Atm1) of mitochondria, the IMS 
sulfhydryl oxidase Erv1, and GSH.  This export system is crucial to both the maturation 
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of cytosolic Fe-S proteins and the regulation of cellular iron uptake (Kispal G et al 1999). 
It was also suggested that ATMs transfer the intermediate of Fe-S cluster because of high 
iron accumulation in mitochondria of a yeast ∆atm1 mutant (Kispal G et al 1997). In 
order to emphasize Atm1’s role in this export process, a recent study demonstrated that 
Arabidopsis ATM3 and yeast Atm1 transport glutathione trisulfide (GS-S-SG) for Fe-S 
cluster assembly in the cytosol (Schaedler TA et al 2014).  
 Another member of the ISC export machinery is GSH. Yeast ∆atm1 mutant cells 
showed increased GSH in mitochondria.  In addition, GSH stimulates Atm1 ATPase 
activity suggesting that GSH may function in the export process (Kispal G et al 1997 and 
Kuhnke G et al 2006). In addition, Kispal and coworkers showed that depletion of GSH 
resulted in defects in maturation of cytosolic Fe-S proteins and promoted mitochondrial 
iron accumulation, but did not affect maturation of mitochondrial Fe-S proteins, implying 
that GSH performs a novel and specific function in this pathway (Sipos K et al 2002). 
GSH depletion or any defects in the ISC assembly machinery or ISC export machinery 
(Erv1 or Atm1) result in constitutive activation of Aft1/2 and induction of iron regulon 
genes that encode proteins involved in cellular iron uptake and intracellular iron 
distribution (Rutherford JC et al 2005) (Figure 1.4). Nevertheless, as mentioned above, 
according to a recent study, GSH is part of the exported molecule as a GSH trisulfide 
(GS-S-SG) carried out by Arabidopsis ATM3 and yeast Atm1 (Schaedler TA et al 2014). 
Consistent with these results, the recently solved crystal structures of yeast Atm1 and 
bacterial Atm1-type ABC transporter include bound GSH in a positively charged binding 
pocket (Srinivasan V et al 2014). In addition, our lab pointed out that the importance of 










































Figure 1.4 Putative Roles for Erv1, GSH, and Atm1 in Cytosolic Fe-S Cluster 
Biogenesis and Iron Regulation. Glutathione tripeptide (GS-S-SG) is generated by 
the mitochondrial ISC assembly machinery and exported by the mitochondrial ABC 
transporter Atm1. Erv1 and GSH are proposed to play roles in exporting this sulfur-
containing compound needed for assembling cytosolic Fe-S clusters and regulating 
Aft1. GSH-ligated, [2Fe-2S]-bridged Grx3/4 homodimers are also required for both 
cytosolic Fe-S cluster biogenesis and iron regulation. 
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required for both cytosolic Fe-S cluster biogenesis and iron regulation (Li H et al 2012). 
Similar to GSH depletion, GSH overaccumulation led to significant impacts on iron 
metabolism. Toledano and coworkers indicated that the fundamental function of GSH is 
linked to iron metabolism, which requires very low amounts of the tripeptide (Kumar C 
et al 2011).  
 The last partner in the export process is the sulfhydryl oxidase Erv1 located in the 
intermembrane space. In one study, a temperature-sensitive erv1 mutant (erv1ts) exhibited 
severe defects in the maturation of cytosolic Fe-S proteins (Lange H et al 2001) similar to 
∆atm1 and ∆gsh1 mutants. When Erv1 function is compromised at the non-permissive 
temperature (37 °C) in this strain, maturation of the cytosolic Fe-S proteins Leu1 
(isopropylmalate isomerase) and Rli1 (Rnase L inhibitor) is strongly impaired. Lill and 
coworkers also analyzed activities of several mitochondrial Fe-S cluster-containing 
enzymes such as aconitase, succinate dehydrogenase and cytochrome c reductase, and 
reported that Erv1 did not impact the activities of these enzymes. Additionally, the free 
iron levels of mitochondria in the erv1ts strain was reported to be 20 times higher iron 
than that found in wild-type mitochondria. However, the molecular mechanism of Erv1 
and its function in this process is unknown. Furthermore, it is not known whether Mia40 
is also required for this pathway. 
Scope of Thesis. This thesis outlines the role of redox pathways in the IMS on GSH 
metabolism and subcellular thiol-disulfide redox homeostasis in different compartments 
thus helping characterize their role in cytosolic Fe-S biogenesis and iron homeostasis. 
Chapter 2 focuses on how mutations and depletion of Erv1 influence GSH metabolism 
and GSH:GSSG pools in the cytosol, mitochondrial matrix and intermembrane space. 
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Chapter 3 investigates whether mutations on Mia40 affect the GSH:GSSG redox status of 
the cytosol, matrix, and intermembrane space and cellular GSH:GSSG pools. Chapter 4 
focuses on determining how the deletion of the inner membrane transporters Mtm1 and 
Yhm2 influence the nearby compartments. Finally, Chapter 5 provides detailed 
experimental protocols developed in the lab to complete these experiments. 
 Thiol-disulfide redox balance is crucial for the Erv1-Mia40 import pathway since it 
plays a role in importing cysteine-rich proteins from the cytosol into the IMS. Mutations 
in Erv1 create several distinct phenotypes, such as decreased import of small IMS 
proteins, mitochondrial morphology changes, defects in Fe-S cluster biogenesis and 
maturation, and defects in iron metabolism. The role of Erv1 dysfunction on GSH 
metabolism was studied by using different erv1 mutants in Chapter 2. We used different 
strains including temperature-sensitive erv1 mutants and a GAL-regulated ERV1 strain 
and tested their GSH levels and Mia40 oxidation. Only one erv1 mutant (erv1-1) 
exhibited defects in GSH biosynthesis for all strains tested. In addition, we expressed 
cytosol-, IMS- or matrix-rxYFP in erv1 temperature-sensitive mutants to determine the 
effects of Erv1 dysfunction on the redox status of subcellular compartments and we 
found that only the erv1-1 mutant shows more oxidizing redox state in cytosol, matrix, 
and IMS due to severely decreased levels of total GSH. We further investigated the 
reason of GSH depletion in erv1-1 mutant and discovered that this mutant has a point 
mutation in the gene encoding the GSH biosynthesis enzyme, Gsh1. Furthermore, we did 




 The oxidoreductase and import receptor Mia40 facilitates IMS import of a broad 
range of substrate proteins for the Erv1-Mia40 import pathway. Mia40 is also shown to 
bind a Fe-S cluster in vitro and in vivo. The impact of mia40 mutations on GSH 
metabolism and subcellular GSH:GSSG redox state were examined in Chapter 3. We 
expressed cytosol-, IMS- or matrix-rxYFP in mia40 temperature-sensitive mutants to 
detect the effects of Mia40 dysfunction on the redox changes. In addition, along with 
GSH assay, we found that defects on Mia40 influence only IMS redox state and does not 
alter cellular GSH levels. Finally, we determined that defects in mia40 do not impact Fe-
S cluster biogenesis or iron regulation in yeast.  
 Mitochondrial inner membrane carrier proteins are involved in the translocation of 
various metabolites, nucleotides, and coenzymes between mitochondrial matrix and 
cytosol.  The impact of the deletion of two mitochondrial carrier proteins, Mtm1 and 
Yhm2 on total GSH levels and subcellular GSH:GSSG redox state was determined in 
Chapter 4. Studies utilizing the redox sensors roGFP2 and Grx1-roGFP2 were performed 
to investigate the GSH:GSSG redox state of intermembrane space, matrix, and cytosol in 
mtm1∆ and yhm2∆ mutants. Based on the results, the mtm1∆ has the highest oxidized 
roGFP2 and Grx1-roGFP2 ratio in the IMS. In order to confirm the roGFP2 data, 
mitochondrial and cytosolic GSH levels were measured by Dr. Daithankar and he found 
that mtm1∆ possesses comparatively low mitochondrial GSH levels. According to these 
results, Mtm1 might transport a solute that directly or indirectly influences GSH 
metabolism.   
  In Chapter 5, detailed methods for the protocols developed or modified during the 
course of study are described. These methods include quantitative real-time PCR, whole 
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cell GSH measurement for temperature-sensitive mutants by using the Promega GSH-
GSSG Glo Kit, and blotting conditions for Erv1 and Gsh1 proteins. 
 In summary, we successfully characterized the role of Erv1 and Mia40 in GSH 
metabolism, mitochondrial import and subcellular redox state which hereby helps to 
reveal their roles in Fe-S cluster biogenesis and iron regulation. Discovering a secondary 
mutation in erv1-1 mutant causing GSH depletion and testing GSH levels in several erv1 
and mia40 mutants aimed to rule out a significant role for Erv1 or Mia40 in cytosolic Fe-
S assembly and iron homeostasis. In addition, in Chapter 4, the role of inner membrane 
transporters on GSH:GSSG redox balance was studied. Further studies will provide new 
insights about whether they play a role in GSH transport or redox homeostasis in the 
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Erv1 is a FAD-dependent sulfhydryl oxidase that partners with the import 
receptor Mia40 to import small cysteine-rich proteins into the mitochondrial 
intermembrane space. A previous study suggested that Erv1 has an additional role in 
maturation of cytosolic Fe-S cluster proteins and regulation of iron homeostasis in S. 
cerevisiae. However, these studies were performed on one particular erv1 mutant strain 
(named as erv1-1) that we discovered has additional defects in glutathione (GSH) 
metabolism. In this study, we found that the erv1-1 strain possesses extremely low total 
GSH levels. Since GSH is also required for iron regulation and cytosolic Fe-S cluster 
assembly, we investigated the Erv1-dependent connection between mitochondrial protein 
import, GSH metabolism, and the subcellular GSH:GSSG redox state. We tested Mia40 
oxidation and GSH levels in a variety of erv1 mutants. While all the erv1 mutants tested 
show defects in Mia40 oxidation, only the erv1-1 strain has significantly lower GSH 
levels. We determined that the cause of GSH depletion in the erv1-1 strain is an 
additional mutation in the gene encoding the GSH biosynthesis enzyme gamma-
glutamylcysteine synthetase (Gsh1) that compromises Gsh1 protein folding and/or 
stability.  We also showed that the GSH depletion phenotype seen in erv1-1 strain could 
be rescued by expressing GSH1 or adding GSH to the growth media. Additionally, we 
measured mRNA and proteins levels of Gsh1 to confirm the instability or unfolding of 
Gsh1 protein in the erv1-1 strain. We also investigated the influence of erv1 mutations on 
the subcellular GSH:GSSG redox state and showed that erv1 mutations led to a more 
reduced IMS redox state. Nevertheless, complementation studies demonstrated that 
GSH1 could not replace ERV1 in cell growth assays. On the other hand, erv1-1 cells 
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expressing ERV1 were able to restore the growth of erv1-1 cells. Together, this study 
suggests that the defects of cytosolic Fe-S maturation and iron regulation first reported in 
the erv1-1 strain is a direct consequence of GSH depletion rather than indicating a direct 
role for Erv1 in iron metabolism and cytosolic Fe-S cluster biogenesis. 
INTRODUCTION 
The mitochondrial intermembrane space (IMS) is a unique subcellular 
compartment that houses key thiol-dependent redox pathways. The mitochondrial Mia40-
Erv1 disulfide relay system facilitates protein import and protein folding in the IMS 
(Sideris DP et al 2010 and Riemer J et al 2011). Reduced and unfolded substrate proteins 
translocate across the outer mitochondrial membrane (TOM), are recognized and become 
oxidized by Mia40 redox active center following the generation of an intramolecular 
disulfide bond, which results in reduction of the Mia40 CPC motif. In order to initiate a 
new reaction cycle, Mia40 is reoxidized by the N-terminal domain of Erv1 forming 
reduced Erv1. Erv1 can then transfer electrons to cytochrome c via the FAD domain of 
Erv1 or directly to oxygen which forms H2O2 (Bihlmaier K et al 2007 and Tienson HL et 
al 2009). In vitro, GSH has been shown to impact substrate oxidation by removing stable 
off-pathway complexes between Mia40 and its substrates (Bien M et al 2010). 
The ERV1 gene is essential for cell viability and vital for a functional respiratory 
chain in yeast. Mutations in the yeast ERV1 gene result in morphological changes in 
mitochondria, and irreversible damage of mitochondria (Becher D et al 1999). Erv1 is 
also required for the cell division cycle and maintenance of the mitochondrial genome in 
yeast (Lisowsky T et al 1992). Moreover, cells with impaired Erv1 have defects in the 
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import of small Tim proteins, decreased amounts of IMS proteins, and deficient 
respiratory complex function (Mesecke N et al 2005 and Di Fonzo A et al 2009). Mia40 
is an essential IMS import receptor possessing a redox-active CPC motif that is oxidized 
by a disulfide relay system consisting of Erv1, cytochrome c and cytochrome c oxidase. 
Defects in Mia40 function through mutations or depletion of Mia40 prevents the import 
of cysteine-rich substrate proteins (Chacinska A et al 2008 and Chacinska A et al 2004). 
Mia40 is partially oxidized in intact wild-type yeast cells and reacts slowly with GSH in 
vitro despite a very reducing surrounding GSH pool. Its redox state is influenced by 
cytosolic glutathione reductase levels, Erv1, reducing substrates and GSH (Bien M et al 
2010). 
GSH is the primary intracellular low molecular weight thiol and serves as an 
antioxidant to scavenge reactive oxygen species (ROS) and electrophiles. GSH is 
synthesized in two steps via γ-glutamylcysteine synthetase, encoded by GSH1 and GSH 
synthase, encoded by GSH2. First of all, Gsh1 conjugates glutamate and cysteine yielding 
γ- glutamylcysteine. Second, Gsh2 adds glycine to γ-glutamylcysteine and produces the 
tripeptide GSH. The rate-limiting step in GSH biosynthesis is Gsh1 that is feedback 
inhibited at the enzyme level by GSH (Meister A et al 1983). Therefore, Gsh1 expression 
rate is very crucial to determine the rate of GSH biosynthesis. In addition to its 
biochemical and antioxidant functions, GSH is also important for cytosolic Fe-S 
biogenesis. GSH depletion disrupts the maturation of cytosolic Fe-S proteins and leads to 
drastic accumulation of iron in mitochondria (Sipos K et al 2002). The activity of the Fe-
S protein Leu1 (Isopropylmalate isomerase) and de novo Fe-S cluster assembly into both 
Leu1 and Rli1 (RNase L Inhibitor) proteins were impaired upon GSH depletion. 
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However, enzyme activities of mitochondrial Fe-S proteins and de novo incorporation of 
55Fe into the mitochondrial Fe-S protein Bio2 (Biotin synthase) were unaffected (Sipos K 
et al 2002). Nonetheless, depletion of GSH also caused constitutive activation of the 
Aft1/2 iron regulon (Rutherford JC et al 2005).  
Besides involvement in the Erv1-Mia40 import pathway, the IMS sulfhydryl 
oxidase Erv1 is also implicated in the biogenesis of cytosolic Fe-S proteins, together with 
the mitochondrial transporter Atm1 and GSH. The mitochondrial ISC assembly 
machinery is required for the biogenesis of both mitochondrial and cytosolic/nuclear Fe-S 
proteins and affects cellular iron metabolism. The ATP binding cassette (ABC) 
transporter Atm1 in yeast mitochondria exports glutathione persulfide (GS-S-SG) to the 
cytosol that is crucial for both the maturation of cytosolic Fe-S proteins and the 
regulation of cellular iron uptake (Stehling O et al 2013 and Schaedler TA et al 2014). 
Erv1 has been implicated in this process since inactivation of Erv1 (by using erv1-1 
temperature sensitive mutant) led to defects in the maturation of cytosolic Fe-S proteins 
(Lange H et al 2001). Upon inactivation of Erv1 at the non-permissive temperature 
(37°C), cytosolic Fe-S proteins maturation (Leu1 and Rli) was strongly decreased in 
comparison with wild-type cells or erv1-1 cells grown at 24°C. However, Erv1 
impairment did not impact the activities of mitochondrial Fe-S enzymes but resulted in 
the accumulation of iron in mitochondria (Lange H et al 2001). 
Since GSH and Erv1 are each required for cytosolic Fe-S cluster assembly, we 
wanted to assess whether there is any connection between GSH and Erv1 function and 
how the mutations of Erv1 influence the subcellular GSH:GSSG redox state in the IMS. 
We transformed cytosol-, matrix-, and IMS-rxYFP into erv1 temperature-sensitive 
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mutants and found that only erv1-1 strain possesses more oxidized redox state in all 
compartments. Since both the GSH:GSSG ratio and total GSH affect the rxYFP redox 
state, additionally, we measured total GSH levels in cytosolic and mitochondrial extracts 
in erv1-1 mutant and additional erv1 mutants and found that erv1-1 strain has severely 
low GSH levels in cytosolic and mitochondrial fractions. To reveal the reason of the GSH 
depletion in erv1-1 strain, we measured total GSH levels in several different erv1 
mutants. We found that of all the erv1 mutants tested, only the erv1-1 strain has 
dramatically lowered GSH levels. We determined that the cause of GSH depletion in the 
erv1-1 strain is an additional mutation in the gene encoding the glutathione biosynthesis 
enzyme Gsh1 which likely compromises Gsh1 protein folding and/or stability.  Iron 
misregulation was only found in the erv1-1 strain and is rescued with GSH addition to the 
growth media. In addition, erv1 mutants did not show any significant changes in activity 
of the human cytosolic Fe-S assembly reporter IRP1. This suggests that the defects of 
cytosolic Fe-S maturation and iron homeostasis seen in erv1-1 mutant might be a 
consequence of GSH depletion caused by a mutation in the GSH1 gene of this strain, 
rather than indicating a direct role for Erv1 in iron metabolism.  
EXPERIMENTAL PROCEDURES  
Yeast Strains, Media, and Growth Conditions—S. cerevisiae strains used in this study 
are listed in Table 2.1. erv1 and mia40 strains were grown on synthetic complete medium 
(SC) supplemented with 2% glucose and the appropriate amino acids overnight at 24 ºC, 
and one set was shifted to 37 ºC and grown for 5 more hours until the cells reach mid-log 
phase (OD between 1-2). The GAL-ERV1 strain was maintained at 30 ºC on synthetic 
complete medium (SC) supplemented with either 2% raffinose and 0.5% galactose and 
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the appropriate amino acids for 24h to overexpress Erv1. In order to deplete Erv1, cells 
were grown on SC media with 2% raffinose for 64h. erv1-1 mutant cells expressing 
pRS415 (empty plasmid), ERV1, and GSH1 expressing plasmids were grown overnight 
on synthetic medium SC (-Leu) supplemented with 2% glucose. erv1(F124S) mutant was 
created by Rabindra Behera by using a plasmid shuffling technique. For plasmid 
shuffling, an erv1 deletion strain with wild-type Erv1 expressed on a URA3 plasmid 
(Spore 2A) was transformed with a TRP1 plasmid carrying Erv1(F124S) (pYX232-
erv1(F124S). Transformants were selected on SC-Trp plates and shuffling of the URA3-
marked plasmid expressing WT Erv1 was carried out with 5-fluoroorotic acid. Spore 2A 
strain and pYX232-ERV1 plasmid were obtained from Jan Riemer (Universität 
Kaiserslautern, Germany). Yeast transformations were performed by the lithium acetate 
procedure (Gietz RD et al 1995). For spot assays, overnight cultures were adjusted to 
OD600=1 and 5 µl of serial dilutions (10-fold each) were spotted on enriched yeast 
extract-peptone-based medium supplemented with 3% glycerol at 37 ºC for 2 days. For 
cloning of Erv1 into erv1-1 strain, the ERV1 gene was cloned from pYX232 (2µ TRP1 
plasmid), which harbors wild-type ERV1 under the TPI1 promoter, into the LEU- 
containing plasmid pYX142 (Bien M et al 2010). 
Plasmids- rxYFP sensors used in this study, including pHOJ150 (cytosol-rxYFP LEU2-
YIp), pJH200 (IMS-rxYFP LEU2-YIp), and pLD206 (matrix-rxYFP LEU2-YIp), were 
described previously (Hu, 2010). The 2µ TRP1 plasmid pYX232-erv1(F124S) was 
generated by Rabindra Behera by site-directed mutagenesis of pYX232-ERV1 (Bien et al, 
2010)) using the QuikChange II Mutagenesis kit (Agilent). The CEN LEU2 plasmid 
p415-ADH-GSH1 was constructed by insertion of the GSH1 open reading frame in the 
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XbaI and XhoI sites of p415-ADH (Mumberg D et al 1995). All plasmid sequences were 
verified by DNA sequencing. 
Subcellular Fractionation—Yeast cells were grown aerobically to mid-log phase in 
selecting SC medium with 2% glucose. Mitochondrial and post-mitochondrial 
supernatant (PMS) fractions were obtained as previously described by converting cells to 
spheroplasts followed by gentle lysis by Dounce homogenization and differential 
centrifugation (Daum G et al 1982). 
Glutathione Assay- Total glutathione was measured by the DTNB-GR (Glutathione 
reductase) recycling assay as described previously (Strain J et al 1998). Freshly made 
PMS and mitochondria extracts were deproteinated by the addition of 10% 5-
sulfosalicylic acid (SSA) to a final concentration of 1% to prevent spontaneous oxidation 
of reduced glutathione and incubated on ice for 30 min. Precipitated protein was then 
removed by centrifugation at 13,000 × g for 5 min. Total glutathione was measured by 
adding 20 μL acidified lysate to 1 mL assay mixture (100 mM sodium phosphate, pH 7.5, 
1 mM EDTA, 0.2 mM NADPH, 0.2 mM DTNB) that had been pre-warmed to 30 °C. The 
assay mixture was transferred into a cuvette by adding 1 unit of GSSG reductase. Assay 
mixture is mixed widely and then the change in absorbance at 412 nm was measured for 
2 min. Glutathione solubilized in 1% SSA was used as standard curves and the rate of 
increase in absorbance was proportional to the amount of glutathione over this range.  
Glutathione Assay by using the GSH/GSSG-GloTM Kit- Total glutathione was measured 
by GSH/GSSG-GloTM Kit (Promega, USA) following the manufacturer’s protocol with 
slight modifications. 4-5×105 cells were harvested by centrifugation and suspended in 
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lysis buffer supplied by the kit. Whole cell extracts were performed through mechanical 
disruption using glass beads. Based on manufacturers’ indications, desired reactions were 
performed and stable luciferin luminescent signals were detected using Synergy H1 
Hybrid Multi-Mode Microplate Reader (Biotek, USA). The luminescent signals were 
proportional to the amount of GSH and correlated with the total cell amount. The results 
are expressed in nM of GSH per 107 cell. See Chapter 5 for the details. 
Redox Western- Redox Western blot analysis of rxYFP and Mia40 was measured by as 
previously described (Hu J et al 2008). Cells were grown in SC media to mid-log phase 
and then acid-quenched with trichloroacetic acid (Sigma) (15% (w/v) final concentration) 
at 4 °C for 20 min. Five A600 units of cells were harvested by centrifugation and 
resuspended in 1 ml of 10% trichloroacetic acid. Following glass bead lysis, the lysed 
cells were transferred to a new tube and pelleted by centrifugation. The pellet was 
resuspended in 500 μl of 1X non-reducing SDS sample buffer containing 40 mm N-
ethylmaleimide (Sigma). Following a 10-min incubation at room temperature, the 
proteins were separated on a 16% Tris-glycine gel (Invitrogen). Reduced and oxidized 
forms of rxYFP and Mia40 were analyzed by quantitative immunoblot using an Odyssey 
Infrared Imaging System (LI-COR). 
Immunoblotting Techniques- Cytosolic and mitochondrial fractions were subjected to 
electrophoresis on Tris-glycine gels (Invitrogen) and analyzed by Western blotting using 
an anti-Erv1 (kind gift of J.Riemer) or anti-Gsh1 (kind gift of J. Barycki) and a secondary 
anti-rabbit IgG (IRDye, LI-COR Lincoln, NE). Cytosolic fractions were monitored by 
anti-3-phosphoglycerate kinase (Pgk1) antibody (Invitrogen). Mitochondrial fractions 
were monitored by anti-Porin (Invitrogen). Proteins were analyzed by Western blot using 
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an Odyssey Infrared Imaging System (LI-COR). Protein concentrations were determined 
using the Bradford method (Bio-Rad) with bovine serum albumin as the calibration 
standard. 
GSH1 Gene Sequencing- Genomic DNA for JRY-675 and erv1-1 strains was isolated by 
using Promega Wizard Genomic DNA Purification Kit and the GSH1 gene amplified 
from –720 to +2380 by PCR using primers listed in Table 2.  Resulting DNA fragment 
was purified by Gel/PCR DNA Fragments Extraction Kit from IBI. The sequence 
integrity of PCR fragments were verified by double-stranded DNA sequencing (USC 
Selah Clinical Genomics Center at Innovista (Columbia, SC).  
RNA Isolation and qRT-PCR- Total RNA was isolated from JRY-675 and erv1-1 strains 
with the PureLink RNA Mini kit (Invitrogen, California) following the manufacturer’s 
protocol by using lysis buffer supplied by the kit. Yeast RNAs were reverse transcribed 
into cDNAs with SuperScript III (Invitrogen) following the manufacturer’s 
recommendations. The Real-time reverse-transcription PCR (qPCR) was carried out on 
IQ ICycler (Biorad) with RT2 SYBR Green Fast Mastermix kit (Qiagen) by using the 
primers shown in Table 2. ).  The relative quantification of GSH1 expression was 
calculated by the 2-ΔΔCT method (Livak KJ et al 2001) using the ACT1 gene (actin) as a 
control. See Chapter 5 for the details. 
β--galactosidase Assays- This assay was performed by C. Outten group member 
Adrienne Dlouhy. All strains tested were transformed with the FET3-lacZ reporter 
construct pFC-W that contains the FET3 iron-response element in a minimal promoter 
(Yamaguchi-Iwai et al, 1996). Temperature-sensitive erv1, and corresponding parent 
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strains were grown in selecting SC glucose media at 24 °C to an OD600 of 1 and then 
divided into 3-ml aliquots for induction.  The cultures were incubated at 24 and 37 °C 
with either 50 μM FeCl3 (high Fe), 100 μM bathophenanthroline disulfonate (BPS) (low 
Fe), or no addition (normal Fe) for 5 hours.  GAL-ERV1 and the parent W303A strain 
were grown for 64 hours at 30 °C to an OD600 of 1 in inducing (SC-raffinose/galactose) 
or repressing (SC-raffinose) media and were divided similarly into high, low, and normal 
Fe aliquots and grown for an additional 4 hours at 30 °C.  Cells were then harvested and 
assayed for β-galactosidase activity as previously described (Thorvaldsen et al, 1993). 
In-Gel Aconitase Activity Assay- This assay was performed by C. Outten group member 
Adrienne Dlouhy. Cytosolic and mitochondrial aconitase activities were monitored using 
an in-gel activity assay described previously (Tong & Rouault, 2006).  Yeast cells 
expressing human cytosolic aconitase IRP1 (pRS425-IRP1 kindly provided by A. 
Dancis) were grown to mid-log phase in selecting SC media, harvested and washed with 
sterile water.  The pellets were then resuspended in lysis buffer (50 mM Tris-HCl, pH 
8.0, 10% glycerol, 50 mM NaCl, 2.5% Triton X-100, 0.5 mM PMSF, 1 mM DTT, 2 mM 
citrate, protease inhibitor cocktail, 200 U/ml catalase) and subjected to glass bead lysis.  
Extracts were centrifuged and the supernatants were collected for assaying.  A chilled 8% 
Tris-borate-citrate polyacrylamide gel was pre-electrophoresed in Tris-glycine-citrate 
running buffer at 140 V for 40 min.  Subsequently, 100 μg of protein was loaded to the 
gel and electrophoresed at 140 V for 3.5 hours on ice.  Gels were incubated at 37 °C for 
30 min in the dark with aconitase activity assay stain (100 mM Tris-HCl, pH 8.0, 1 mM 
NADP+, 2.5 mM cis-aconitate, 5 mM MgCl2, 1.2 mM MTT, 0.3 mM phenazine 
methosulfate, and 5 U/ml isocitrate dehydrogenase) and scanned 
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Table 2.1 Strains used in this study 
Strain Genotype Reference 




MATa, ∆leu2, ura3-52, pet492ts (Lisowsky T 
1992) 
YPH499 MATa, ade2-101, his3-∆200, leu2-∆1, ura3-52, trp1-
∆63, lys2-801 
(Sikorski RS et 
al 1989) 
erv1-2 MATa, ade2-101, his3-∆200, leu2-∆1, ura3-52, trp1-
∆63, lys2-801, erv1∷ADE2 [pFL39-erv1-2] 
(Rissler M et al, 
2005) 
erv1-5 MATa, ade2-101, his3-∆200, leu2-∆1, ura3-52, trp1-
∆63, lys2-801, erv1∷ADE2 [pFL39-erv1-C159S] 
(Muller JM et al 
2008)  
W303A MATa, ade2-1, his3-11,15, leu2-3,112, trp1-1, ura3-1, 
can1-100  
 






MATa, ade2-1, his3-11,15, leu2-3,112, trp1-1, ura3-1, 
can1-100 erv1::HIS3 [pERV1(URA3)] 
(Bien M et al 
2010) 
W303-ERV1 MATa, ade2-1, his3-11,15, leu2-3,112, trp1-1, ura3-1, 




MATa, ade2-1, his3-11,15, leu2-3,112, trp1-1, ura3-1, 




trp1-1, ura3-1, leu2-3,112, his3-11,15, ade2-1, can1-
100, GAL2+, met2-Δ1, lys2- Δ2, erv1::TRP 
(Aloria K et al 
2004) 
W303 MATa ura3-1 ade2-1 trp1-1 his3-11, 15 leu2-3, 
112[rho+] 








Table 2.2 Primers used for sequencing and qRT-PCR.  
Primer Name Primer Sequence 
GSH1 Sequencing Primers 
GSH1 -700  5′-GTTTGGTTCAGCGCGACGAG-3′ 
GSH1 term  5′-CAGGAGATTCCAGGTTCGAG-3′ 
GSH1 seq forward 5′-GCTAGCCGACCAAGATGTTC-3′ 
GSH1 seq reverse 5′-CAATGCCTCCAAATCCGTTC-3′ 
qRT-PCR Primers 
GSH1 forward 5′- TCTAGGACGTACAATGAACAC-3′ 
GSH1 reverse 5′- CCTCCATATTAAGCTCAGTG -3′ 
ACT1 forward 5′- GGATTCCGGTGATGGTGTTACT -3′ 



















Only erv1-1 shows a GSH depletion phenotype. To uncover whether there is any linkage 
between Erv1 and GSH metabolism, we measured total GSH levels in the erv1-1 strain. 
First, the redox state of Mia40 was analyzed to verify the defect of Erv1 in this strain. 
erv1-1 temperature sensitive mutant shows normal function when grown at 24 °C, but 
exhibits defects in IMS protein import when grown at 37 °C (Becher D et al 1999 and 
Rissler M et al 2005). Since Mia40 includes a redox-active disulfide bond that is oxidized 
by Erv1, malfunctions in Erv1 will cause reduction of this disulfide in Mia40 (Figure 2.1-
A). We grew the erv1-1 strain overnight at the permissive temperature (24 °C) and then 
switched them to the restrictive temperature (37 °C) for 5 hours to impair Erv1 function. 
As expected, erv1-1 mutant showed defects in Mia40 oxidation at 37 °C (reduced Mia40, 
~35%)  (Figure 2.1-B). We measured the Mia40 redox state by performing redox western 
blot technique (non-reducing SDS-PAGE). Then, we measured total GSH levels in 
cytosolic and mitochondrial fractions in erv1-1. We noticed a 16-fold decrease of total 
cytosolic GSH levels in the erv1-1 strain compared to WT at 24 °C and 13-fold decrease 
of total cytosolic GSH levels in the erv1-1 strain compared to WT at 37 °C (Figure 2.2-
A). In addition, mitochondrial total GSH levels decreased at both temperatures, however, 
not as much as cytosolic GSH pools (Figure 2.2-B). In order to test whether the GSH 
depletion phenotype discovered in the erv1-1 strain is directly related to the Erv1-Mia40 
import system or unique to that specific mutant, we measured total GSH levels in cytosol 
and mitochondria of additional erv1 strains (Figure 2.2 A-B). Similarly, we determined 
Mia40 redox state for these additional mutants and found that Mia40 was mainly in 
reduced state at 37 °C in all erv1 strains (Figure 2.1-C).  
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Figure 2.1. In vivo Mia40 redox state measurements in erv1 mutants. WT and erv1 
strains were grown to mid-log phase in SD media overnight at 24 ºC, and one set was 
shifted to 37 ºC and grown for 5 more hours. Redox western blots were performed on 
these strains and were immunoblotted with α-Mia40 antibody. Reduced and oxidized 
forms of Mia40 were quantified using an Odyssey Infrared Imaging System. The 
reported values are the mean of 3-4 independent experiments. Error bars are the means 
+ standard deviations. The WT strain used for erv1-1 is JRY675 (WT(1)). The 
isogenic WT strain for erv1-2 and erv1-5 is YPH499 (WT(2)). 















































Figure 2.2 Total GSH values in cytosolic, mitochondrial and whole cell extracts 
for erv1 strains. WT and erv1 strains were grown in SD media overnight at 24 ºC, 
and one set was shifted to 37 ºC and grown for 5 more hours.  The reported values are 
the mean of 4-5 independent experiments. Error bars are the means + standard 
deviations.  The WT strain used for erv1-1 is JRY675 (WT(1)). The isogenic WT 
strain for erv1-2 and erv1-5 is YPH499 (WT(2)). 
 
  




Total GSH levels are only slightly changed in these erv1 strains in both cytosolic and 
mitochondrial fractions (Figure 2.2 A-B).  Furthermore, we tested whole cell GSH levels 
in all erv1 mutants and demonstrated that only erv1-1 mutant possesses severely 
decreased GSH levels in whole cell extracts (Figure 2.2-C). These results showed that 
only the erv1-1 mutant exhibited a GSH depletion phenotype while all the other erv1 
mutants did not. Nevertheless, we questioned whether the specific mutation site of the 
erv1-1 strain is the reason for the GSH depletion. Since the erv1-1 mutant has mutation 
on the site of phenylalanine 124 to serine, an erv1 mutant carrying the same mutation 
(F124S) was recreated in a different strain background by using a plasmid shuffling 
technique. Reduced Mia40 at 37˚C (33% oxidized) in the erv1(F12S) mutant confirmed 
its temperature sensitivity and mutation (Figure 2.3-A). Nevertheless, no significant 
changes were observed in whole cell GSH values between WT and erv1(F124S) mutant 
at both temperatures (Figure 2.3-B). Furthermore, in order to see the effects of Erv1 
depletion on GSH values without any temperature effect, a GAL-ERV1 strain in which the 
ERV1 gene is controlled under the regulatable promoter was used to deplete Erv1 protein. 
GAL-ERV1 cells were cultivated on media with raffinose-galactose (inducing condition) 
or only raffinose (non-inducing condition) and the Mia40 redox state, Erv1 protein levels, 
and whole cell GSH levels were examined. As a control study of this strain as in others, 
we tested the Mia40 redox state.  Reduced Mia40 (~%35 oxidized) was detected as 
expected 64h after shifting to non-inducing conditions, confirming depletion of Erv1 in 
that strain (Figure 2.4-A). Moreover, as shown in Figure 2.4-B, western blot assay 
demonstrated that under the repressive conditions, Erv1 was not expressed in 
mitochondria. More importantly, we did not observe any reduction in whole cell GSH 
41 
 
values between the WT and GAL-ERV1 strains (Figure 2.4 C). On the contrary, we found 
higher GSH values when Erv1 is overexpressed and non-expressed. In addition, in order 
to determine if Erv1 protein expression level influences GSH metabolism, Erv1 levels 
were demonstrated by immunostaining analysis for erv1 strains. Erv1 expression levels in 
mitochondrial fractions mostly decreased at 37 °C on erv1 mutants including erv1-1 and 
showed a similar pattern at 37 °C (Figure 2.5). This result was expected since cells 
lacking functional Erv1 have impaired import of substrate proteins of the Erv1-Mia40 
pathway into the IMS, and Erv1 is a substrate of this pathway. (Rissler M et al 2005 and 
Mesecke N et al 2005). As an additional control to rule out the effects of Erv1 on GSH 
metabolism, an erv1 mutant carrying the same F124S mutation but reported to 
accumulate high mitochondrial iron levels at the non-permissive temperature of 37 °C 
(Aloria K et al 2004) was tested for total GSH measurement (Figure 2.6). We did not 
observe any decrease in total GSH levels in cytosolic and mitochondrial fractions at both 
temperatures and GSH values of this erv1 mutant are very similar to that of WT. Taken 
together, these results demonstrate that only the erv1-1 mutant displayed a severe GSH 
deficiency phenotype independent of the F124S mutation, defective Erv1 levels, and 






















Figure 2.3 in vivo Mia40 redox state and whole cell GSH measurements in erv1-
(F124S) strain A) In vivo Mia40 redox state measurements of WT (W303A) and 
mutant strain erv1(F124S). B) Total GSH values in whole cell extracts for 
erv1(F124S) mutant and WT strain. WT and mutant strains were grown in SD (-Trp) 
media overnight at 24 ºC, and one set was shifted to 37 ºC and grown for 5 more hrs. 
Total cell extracts were prepared by using glass-beads lysis. Error bars represent the 




















Figure 2.4. In vivo Mia40 redox state, immunoblot for Erv1 protein and whole 
cell GSH measurements in GAL-ERV1 strain. A) In vivo Mia40 redox state 
measurements of WT (W303A) strain and GAL-ERV1 strain. Cells were grown in the 
presence of defined medium with both 2% raffinose and 0.5% galactose, centrifuged, 
and resuspended in 2% raffinose to deplete Erv1. B) Immunoblot for Erv1 protein in 
mitochondrial extracts. 20 µg mitochondrial protein were used for western blot 
analysis, respectively. C) Total GSH measurements in whole cell extracts for GAL-
ERV1 and WT strain. Cells were collected following shift to non-inducing condition 

















Figure 2.5 Mitochondrial Erv1 protein levels in erv1 strains. WT and erv1 strains 
were grown in SD media at 24 ºC and 37 ºC and were analyzed by SDS-PAGE and 
immunoblotted with α-Erv1 and α-Porin antibodies. 20 µg mitochondrial protein was 
used. The WT strain used for erv1-1 is JRY675 (WT(1)). The isogenic WT strain for 










































Figure 2.6 Total GSH values in cytosolic and mitochondrial extracts of WT and 
erv1ts mutant carrying F124S mutation with high mitochondrial Fe levels. 
WT(W303A) and erv1ts(F124S) strains were grown to mid-log phase in SD (-Trp) 
media overnight at 24 ºC, and one set was shifted to 37 ºC and grown for 5 more hrs 
and were subjected to GSH assay. 
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Defects in Erv1 result in a more oxidizing GSH:GSSG redox state in the cytosol, 
matrix and IMS. We also wanted to test how GSH depletion in erv1-1 strain and how 
mutations in erv1 affect the GSH: GSSG environment in the cell. We expressed cytosol-, 
IMS-, or matrix-rxYFP in erv1 mutants and monitored the redox state of rxYFP by redox 
western technique. rxYFP was used as an in vivo sensor since the cysteines in rxYFP 
specifically equilibrate with GSH and GSSG via rapid disulfide exchange reactions 
catalyzed by endogenous glutaredoxins (GRXs). In addition, reduced and oxidized forms 
of rxYFP protein show different mobilities by non-reducing SDS-PAGE providing facile 
measurement of the protein’s redox state. The redox western results utilizing the targeted 
rxYFP redox sensors indicated a more oxidized GSH:GSSG redox state in all 
compartments tested (cytosol, matrix, and IMS) in the erv1-1 strain in comparison to the 
WT strain (Figure 2.7). In addition, using the differently-targeted versions of rxYFP, we 
tested the redox state in the cytosol, mitochondrial matrix, and mitochondrial IMS in 
additional erv1 mutants. As shown in Figure 2.7-A, the cytosolic redox state of erv1 
mutants is highly similar to the cytosolic redox state of WT. This finding is logical since 
we did not observe any significant difference in total cytosolic GSH levels in additional 
erv1 mutants. The only difference was seen in erv1-1, which was highly oxidized 
compared to WT (Figure 2.7-A). The matrix redox state in erv1-1 is also compatible with 
total mitochondrial GSH levels tested. erv1-1 strain has dramatically lowered 
mitochondrial GSH levels and showed more oxidized matrix redox state than that of WT 
(Figure 2.7-B). However, other erv1 mutants have no significant impact on matrix GSH: 
GSSG compared to WT (Figure 2.7-B). Additionally, the IMS redox state in the erv1-1 








Figure 2.7 Subcellular GSH:GSSG redox state in erv1 mutants. WT and erv1 
strains transformed with an rxYFP expression plasmid pHOJ150 (cytosol-rxYFP), 
pLD206 (matrix-rxYFP), or pJH200 (IMS-rxYFP) and cells were grown in SD (-Leu) 
selection media. Redox western blots were performed on the indicated strains and 
immunoblotted with α-GFP. Reduced and oxidized forms of rxYFP were quantified 
using an Odyssey Infrared Imaging System. Error bars represent the standard 
deviation for 3-4 independent experiments. 
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redox state was observed in other erv1 mutants at 37 ˚C as expected since malfunction of 
ERV1 causes a defect in the oxidation of substrate proteins and leads to accumulation of 
reduced substrate proteins and reduced IMS GSH:GSSG (Figure 2.7-C). Thus, this data 
indicate that GSH depletion might not be directly related to Erv1 function in this erv1-1 
strain. 
The cause of the GSH depletion in the erv1-1 strain is an additional mutation in the 
gene encoding the glutathione biosynthesis enzyme Gsh1. To uncover the mechanism 
for GSH depletion in this erv1-1 strain, we tested whether this strain exhibited decreased 
GSH synthesis in comparison to WT cells as well as other erv1 and mia40 mutant strains. 
The tripeptide glutathione (GSH) is synthesized in two steps via γ-glutamylcysteine 
synthetase (Gsh1) and GSH synthase (Gsh2).  We measured the protein levels of the first 
GSH biosynthesis enzyme (Gsh1). Cytosolic extract was isolated from erv1 mutant cells 
grown in SD medium and the cytosolic fractions were analyzed by immunostaining. The 
erv1-1 strain shows dramatically decreased Gsh1 protein levels (10-fold at 24 ˚C, 15-fold 
at 37 ˚C) compared to WT at both temperatures (Figure 2.8). However, Erv1 expression 
levels in other erv1 strains were similar to WT. For this western blot assay, Pgk1 (3-
phosphoglycerate kinase) was used as a loading control and the levels of Pgk1 were not 
altered. Additionally, we observed decreased Gsh1 expression at 37 °C for both WT and 
erv1 strains. Next, we questioned if the strong decrease in Gsh1 levels in erv1-1 strain is 
due to a secondary mutation of GSH1 gene. To determine this, we sequenced the GSH1 
gene of erv1-1 and discovered an arginine to histidine mutation at position 280. Arg-280 
is located in a well-conserved region of the Gsh1 protein sequence and is likely important 
for protein folding and stability (Figure 2.9 A-B).  This mutation may be the direct cause 
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of decreased Gsh1 expression levels in this erv1-1 strain. Additionally, we measured 
mRNA levels of the GSH1 gene in erv1-1 to determine whether there are translational or 
post-translational defects in GSH1 expression. We used ACT1 (Actin1) that does not vary 
in expression between different samples as a reference gene and endogenous control and 
showed the results as relative fold change of GSH1/ACT1 (Figure 2.10).  As shown in 
Figure 2.10, we found that mRNA levels of GSH1 were increased in erv1-1 at both 
temperatures as compared to WT.  This upregulation is likely due to decreased Gsh1 
stability and activity, which leads to lower intracellular GSH levels which triggers 
oxidative stress sensing by the transcription factor Yap1 (Wu AL et al 1994 and Wheeler 
GL et al 2003).  Oxidized Yap1 in turn activates expression of the GSH1 gene (Stephen 
DW et al 1997 and Dormer UH et al 2002). In addition, we noticed that WT GSH1 
mRNA levels at 37 ˚C increased as compared to WT mRNA levels at 24˚C. This result is 
consistent with the fact that heat shock causes the activation of Yap1 (Sugiyama K et al 
2000), leading to activation of the GSH1 gene. Taken together, these results demonstrate 
that GSH deficiency in erv1-1 is caused by a previously unknown secondary mutation in 
the Gsh1 protein sequence that likely leads to protein instability. 
Using the erv1-1 strain, a previous study suggested that Erv1 plays a role in 
cytosolic Fe-S cluster biogenesis since this strain showed defects in cytosolic Fe-S cluster 
assembly (Lange H et al 2001). Another study also demonstrated that GSH is essential 
for the maturation of cytosolic Fe-S proteins (Sipos K et al 2002). Therefore, our 
hypothesis was that the cytosolic Fe-S assembly defect reported for the erv1-1 mutant 
strain results from GSH depletion in that specific mutant, rather than indicating a direct 
role for Erv1 in cytosolic Fe-S cluster assembly. Our lab member Adrienne Dlouhy 
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measured iron-dependent expression of the Aft1-regulated gene (FET3) in erv1 strains. 
The FET3 gene, which encodes a multicopper ferroxidase, is required for ferrous iron 
uptake as part of the high affinity iron uptake system at the cell surface and is regulated 
by the transcription factors Aft1 and Aft2 (Philpott CC et al 2008). Induction of FET3 via 
Aft1/2 is linked to Fe-S cluster biogenesis and hereby the activity of the FET3 promoter 
is connected with Fe-S biogenesis (Rutherford JC et al 2005 and Chen OS et al 2004). 
FET3 is normally repressed when cells are iron-replete and becomes activated under 
conditions of iron depletion. However, defects in Fe-S cluster synthesis leads to 
constitutive expression of this gene in the presence of both low and high iron (Outten CE 
et al 2013). Adrienne measured expression of this gene via β-galactosidase assays by 
transforming a FET3-LacZ reporter vector into the erv1 mutants with and without the 
addition of GSH in iron-replete and iron-limited medium. Of all the erv1 mutants tested, 
the only strain to exhibit iron misregulation is the GSH-deficient erv1-1 strain, which 
could be rescued with GSH addition (Figure 2.11). In addition, she expressed human 
cytosolic aconitase (IRP1), which functions as a cytosolic Fe-S assembly reporter, by 
transforming erv1 mutants with a plasmid expressing IRP1 under a strong promoter 
(Zhang Y et al 2008) and found that human cytosolic aconitase (IRP1) activity is similar 
in WT and erv1 mutants (Figure 2.12). Based on the measurements of GSH levels in erv1 
mutants, the measurements of activity of a cytosolic Fe-S protein IRP1 and the 
measurement of expression of iron regulon gene FET3, we suggest that the Fe-S cluster 














Figure 2.8 erv1-1 strain has dramatically decreased Gsh1 protein levels. WT and 
erv1 mutant cells were grown in SD media at 24 °C and 37 °C. Cytosolic fractions 
were isolated and 75 µg cytosolic protein was used for the western blot. Gsh1 and 
Pgk1 bands were quantified using an Odyssey Infrared Imaging System and relative to 
















Figure 2.9 Mutation found in GSH1 gene of erv1-1 strain likely compromises 
Gsh1 protein folding and/or stability. A) Residues in the conserved region of 
gamma glutamylcysteine synthetase (Gsh1) in S. cerevisiae, S. pombe, mouse, rat, and 
human. The position of Arg-280 is indicated with a green arrow. B) Crystal structure 
of yeast Gsh1 enzyme (Biterova E et al 2009). Arg-280 is shown in green and forms a 
salt bridge with Asp-403 (in orange) in a nearby helix. Mg2+ ions in active site are 









Figure 2.10 Real time RT-PCR analysis of mRNA levels of WT and erv1-1 
strains. WT and erv1-1 cells were grown in YPD media at 24 °C and 37 °C and total 
RNA was isolated. Complementary DNA (cDNA) was produced from total RNA by 
using reverse transcriptase. cDNA was used as template for RT-PCR analysis with the 








Figure 2.11 Expression of the Aft1/2-regulated gene FET3. WT, erv1, and GAL-
ERV1 strains were transformed with a FET3-LacZ reporter plasmid and grown at 24 or 
37˚C. β-galactosidase activity was measured for cells grown in medium 
supplemented with iron (high Fe), no iron (normal Fe), or the iron chelator BPS (low 
Fe) in the presence or absence of 1 mM GSH. A) β-galactosidase activity 
measurement of WT (JRY675) and erv1-1 strains. B)β-galactosidase activity 
measurement of WT(YPH499) and erv1 strains. C)β-galactosidase activity 
measurement of WT(W303-A) and GAL-ERV1 strains. Error bars indicate standard 












Figure 2.12 Human cytosolic aconitase activity (IRP1) activity in WT and erv1 
strains. Cytosolic and mitochondrial Fe-S cluster assembly was monitored using an 
in-gel aconitase activity assay in cells expressing human cytosolic aconitase IRP1. 
Aconitase activities for 100 μg of cell lysates were separated by native gel 
electrophoresis. Positions of the endogenous mitochondrial aconitase activity (Aco1) 
and plasmid-expressed cytoplasmic aconitase activity (IRP1) are indicated in erv1-1 
strain (A) and erv1-2 and erv1-5 strains (B). In addition, immunoblots for IRP1 
protein was performed. Whole cell lysates were analyzed by SDS-PAGE and 
immunoblotted with anti-IRP1 (100 μg of protein for each). This assay was performed 
by Adrienne Dlouhy. 
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Complementation of the growth defects of erv1-1 cells.  To address whether GSH 
replaces the function of Erv1 or rescues the GSH depletion phenotype, GSH1 and ERV1 
genes were expressed in erv1-1 mutant cells. We also expressed the GSH1 gene in erv1-1 
by using a plasmid with GSH1 under the control of the TEF1 promoter to see whether 
GSH1 overexpression rescues the GSH depletion phenotype seen in erv1-1. For the 
confirmation of ERV1 complementation, we measured the Mia40 redox state in these 
erv1-1/ERV1 transformants. Expression of WT Erv1 complemented the Mia40 oxidation 
phenotype since Mia40 was primarily oxidized at both 24 °C and 37 °C for erv1-1 cells 
expressing wild-type Erv1 (Figure 2.13-A). For the confirmation of GSH1 
complementation, we measured whole cell GSH in WT, erv1-1 cells with empty plasmid 
(pRS415), and erv1-1 cells expressing GSH1 (Figure 2.13-B). We found that total GSH 
levels in erv1-1 cells expressing GSH1 are very high compared to WT and erv1-1 with 
empty plasmid. Nevertheless, we measured whole cell GSH levels in erv1-1 strain with 
the addition of 1 mM GSH to the growth media since our lab member, Adrienne found 
the recovery in Aft1-regulated gene expression in erv1-1 strain when adding 1 mM GSH 
to the media. Whole cell GSH levels in erv1-1 are increased with 1 mM GSH addition 
which confirms that erv1-1 does not have any defects in GSH uptake (Figure 2.13-B). 
Additionally, we performed western blot assay to check Gsh1 protein levels in erv1-1 
cells expressing GSH1 and found that Gsh1 is highly expressed in these transformants 
(Figure 2.14-C). Thus, immunostaining and GSH measurements show that the GSH 
depletion phenotype is rescued by adding back GSH1 into erv1-1.  
   For the complementation of growth defects of erv1-1 strain, we did spot assays on 
YPG (glycerol) plates. It has been shown that oxidative phosphorylation and the presence 
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of mitochondrial genome are dispensable as long as fermentable carbon sources such as 
glucose or fructose are present in the growth media. In addition, temperature-sensitive 
erv1 strains are not able to grow on media containing non-fermentable carbon sources 
such as glycerol due to defects in respiratory chain assembly (Lisowsky T 1992 and 
Lisowsky T et al 1994). At the permissive temperature (24 °C) when Erv1 functions 
normally, we did not observe any growth defect in erv1-1 with WT ERV1 and erv1-1 
cells expressing GSH1 as expected (Figure 2.14-A). On the other hand, GSH1 could not 
substitute for ERV1 in cell growth assays even though cells have sufficient GSH 
concentrations (Figure 2.14-B). We also used YPG plate with 1 mM GSH for spot tests 
and adding GSH to the growth media did not help to rescue Erv1 defects in erv1-1. 
However, erv1-1 cells expressing ERV1 were able to fully restore the growth of erv1-1 


















Figure 2.13 Confirmation assays for complementation of erv1-1 strain. A) Mia40 
redox state for WT (JRY 675), erv1-1, erv1-1 with empty plasmid (pRS 415) and 
erv1-1 with WT Erv1. B) Total GSH levels in whole cell extracts. C) Western blotting 
against Gsh1 and Pgk1. 75 µg cytosolic extracts were used for western blotting and 










Figure 2.14 Spot testing of cell growth with wild-type (JRY675), and erv1-1 
mutant cells expressing pRS415 (empty plasmid), ERV1, and GSH1. Cells were 
analyzed by spotting 5 µl of cells, at OD600 values of 1.0, 0.1, and 0.01 onto YPG and 




 The sulfhydryl oxidase Erv1, one of the components of the Erv1-Mia40 disulfide 
relay system in the IMS, was originally characterized as a new gene essential for cell 
viability and for functional respiratory chain activity in yeast (Lisowsky T et al 1994). 
Besides its role as a redox partner with Mia40, it was proposed that Erv1 also contributes 
to the biogenesis of cytosolic Fe-S cluster proteins and cellular iron homeostasis. In a 
previous study published by Roland Lill’s group, cytosolic Fe-S protein defects were 
found in the erv1ts mutant strain (named as erv1-1 in this study) at the non-permissive 
temperature (37 °C), while no mitochondrial Fe-S cluster defects were found (Lange H et 
al 2001). In addition to Erv1, GSH has been reported to impact cytosolic Fe-S proteins 
maturation since both depletion and overaccumulation of GSH causes impaired cytosolic 
Fe-S cluster biogenesis (Sipos K et al 2002, Kumar C et al 2011). Our research 
demonstrated that the erv1-1 mutant strain has much lower GSH levels than the 
corresponding WT strain. Since GSH is required for cytosolic Fe-S cluster maturation 
(Sipos K et al 2002), it is important to determine whether the GSH depletion in this 
mutant is the underlying cause of the cytosolic Fe-S cluster biogenesis defects rather than 
loss of Erv1 function. In order to investigate this, we tested if other erv1 strains show 
GSH decrease or this phenotype is unique to this erv1-1 strain. Our results indicate that 
the erv1-1 mutant strain exhibits GSH depletion at both temperatures while the other erv1 
mutant strains did not. Moreover, Mia40 was still significantly more reduced in these 
strains at 37 °C as compared to WT. Therefore, these findings suggest that severe GSH 
depletion upon Erv1 dysfunction is unique to the erv1-1 strain and is not the direct reason 
of the Mia40 oxidation defect seen in all the strains tested.  
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 Our next step was to question the reason for the GSH depletion in the erv1-1 
mutant. We know that this mutant has a F124S mutation in the ERV1 gene. In order to 
test if this single mutation is the cause of the GSH depletion phenotype seen in erv1-1, 
we tested the same mutation in a different genetic background. Interestingly, we did not 
observe any GSH decrease in this newly created erv1-(F124S) mutant even though it 
exhibits Mia40 oxidation defect at the restrictive temperature, thus suggesting that the 
F124S single point mutation is not the cause for GSH depletion in erv1-1.  
 Moreover, in order to examine how changes in Erv1 expression affects GSH levels 
which is independent of temperature effects, we tested a GAL-ERV1 strain. Erv1 
depletion did not lead to reduction in GSH levels. On the other hand, both Erv1 
overexpression and depletion led to somewhat increased total GSH levels in whole cell 
extracts. Increased total GSH levels in the absence of Erv1 function might be due to an 
oxidative stress generated by the accumulation of H2O2. Dabir et al demonstrated that 
oxygen serves as the final electron acceptor for Erv1-mediated reactions causing the 
release of H2O2, which is subsequently reduced to water by cytochrome c peroxidase. In 
addition, they showed that H2O2 levels increase in erv1 mutants at the restrictive 
temperature, suggesting that one of the Erv1 electron acceptor pathways relies on 
cytochrome c (Dabir DV et al 2007). Consequently, depletion of Erv1 leading to 
increased H2O2 production might activate the Yap1 transcriptional factor. Yap1 induces 
the expression of its target antioxidant genes such as GSH1, GLR1 and GPX1 upon 
oxidative stress such as H2O2 generation. Therefore, upon depletion of Erv1 causing H2O2 
accumulation, Yap1 might induce GSH1 expression leading to the elevated levels of 
62 
 
GSH. In the future, it would be interesting to test if depletion or overexpression of Erv1 
leads to increase in H2O2 levels and also leads to increase in Gsh1 expression levels.  
 We also tested another erv1ts strain that has the same point mutation as erv1-1 but 
in a different strain background (W303).  This strain was reported to accumulate 10-fold 
higher iron than normal in its mitochondria, presumably due to defects in cytosolic Fe-S 
cluster assembly (Aloria K et al 2004). However, we did not observe any decrease in total 
GSH levels in this erv1ts strain.  Furthermore, inconsistent with this previous result, our 
group did not detect any increase in mitochondrial Fe in this erv1 strain (Dlouhy A 2015). 
 Additionally, in order to confirm the GSH assay results, we measured the 
GSH:GSSG redox state in the cytosol, IMS, and matrix of erv1 mutant strains using our 
targeted rxYFP sensors. Cytosol- and matrix-rxYFP are significantly more oxidized in 
the erv1-1 strain as compared to the other strains which is consistent with the severe GSH 
decrease found in this strain. However, IMS-rxYFP is slightly more oxidized in the erv1-
1 strain compared to WT, implying that GSH depletion seen in erv1-1 does not further 
impact the IMS since the IMS redox state is already mostly oxidized. We also found that 
IMS-rxYFP is consistently more reduced in other erv1 mutants than corresponding wild-
type strains at 37 °C. This result is consistent with the fact that the Mia40-Erv1 system 
assures the oxidation of the substrate proteins in the IMS. Disruption of this pathway 
might cause a more reduced GSH:GSSG redox state in this compartment because 
mutations on Erv1 lead to defects on precursor release, formation of the oxidized 
monomers, and eventually inhibition in substrate oxidation (Müller JM et al 2008 and 
Rissler M et al 2005) which causes the accumulation of reduced precursors in the IMS. 
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 Because the F124S point mutation and defective Erv1 are not the cause of the GSH 
depletion phenotype in erv1-1, we decided to check the expression level of the first GSH 
biosynthesis enzyme, Gsh1. Surprisingly, we found dramatically low Gsh1 expression 
and with further studies by sequencing, discovered a mutation in the GSH1 gene 
corresponding to residue 280. Arg 280 is located in a well-conserved region of Gsh1 and 
it forms a salt bridge with Asp 402 (Figure 2.9). It also forms backbone hydrogen bonds 
with Leu 369 and Gly 370 (Biterova EI et al 2009). Disruption of these interaction may 
impact the placement of Tyr 362 in a loop region which helps coordinate the alpha-
carboxylate of the glutamate substrate. Thus, the R280H mutation might indirectly 
impact substrate binding and reduce GSH levels or it might impact protein stability.  
Further structural and enzymatic studies on the Gsh1 R280H mutant are required to 
confirm these effects.  
 In order to rescue the GSH depletion phenotype seen in erv1-1, we added 1 mM 
GSH to the growth media and also expressed the WT GSH1 gene in erv1-1. Either adding 
GSH to the media or ectopic expression of WT GSH1 rescued the GSH depletion 
phenotype in this mutant. We also performed real-time PCR and found that mRNA levels 
of erv1-1 are 4-fold higher than that of wild-type when Erv1 is functional and 2-fold 
higher than that of wild-type when Erv1 is nonfunctional. We also observed that GSH1 
mRNA levels are elevated in wild-type cells at the restrictive temperature. Recently, it 
has been shown that post-translational regulation leads to low correlation between mRNA 
and protein concentrations. Therefore, the processes of translation and protein 
degradation are at least as important as mRNA transcription and stability to steady-state 
protein abundance concentrations (Vogel C et al 2010). Increased mRNA level in erv1-1 
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strain at both temperatures is explained by the fact that mutation in the gene might lead to 
instability, degradation and eventually lowered half-life in the protein triggering the 
resynthesis of mRNA. Moreover, mutated or misfolded proteins are recognized and 
removed by ubiquitin-mediated proteolysis. Increase in the protein degradation rate might 
cause resynthesis of the protein thus more transcription of mRNA since GSH1 is 
expressed ubiquitously in the cell and gsh1∆ cells are not viable (Penninckx M et al 
2000). These findings are also consistent with the increased mRNA levels found in wild-
type strain at restrictive temperature (37˚C). Unstable protein in the presence of high 
temperature degrades and this degradation leads to increased turnover rate of mRNAs 
which is supported by decreased level of Gsh1 expression (Figure 2.8). In addition, GSH 
depletion and heat-shock stress result in activation of the Yap1 transcription factor 
causing increased GSH1 expression leading to increased mRNA levels (Wheeler GL et al 
2003, Sugiyama K et al 2000).  
 To investigate Erv1’s role in iron regulation, our lab member Adrienne Dlouhy 
found that FET3 expression was only misregulated in the GSH-deficient erv1-1 strain 
which is rescued with GSH addition. Furthermore, she established that activity of the Fe-
S cluster enzymes mitochondrial aconitase and cytosolic human IRP1 were unaffected in 
erv1 mutants.  Additionally, our collaborator Janneke Balk’s group determined that only 
the erv1-1 strain showed a small reduction in activity of the cytosolic Fe-S cluster protein 
Leu1. These results demonstrate that the reason of the defects in cytosolic Fe-S protein 
biogenesis and iron homeostasis in the erv1-1 strain is GSH depletion in that strain which 
is confirmed by the additional mutation found in the gene encoding the glutathione 
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 A recently identified disulfide relay system in the mitochondrial intermembrane 
space (IMS) is crucial for importing small, cysteine-rich proteins by facilitating disulfide 
bond formation. The sulfhydryl oxidase Erv1 and the import receptor/oxidoreductase 
Mia40 constituting this system are affected by the redox state of GSH:GSSG in this 
compartment since mitochondrial protein import is stimulated by GSH. Mia40 has been 
shown to bind a Fe-S cluster in vitro and when overexpressed in vivo; however, its 
potential role in Fe-S cluster assembly and iron metabolism has not previously been 
addressed. In order to uncover how the Erv1-Mia40 system impacts GSH metabolism, we 
determined the total GSH in temperature-sensitive mia40 mutants. Our data suggest that 
defective Mia40 leads to no significant difference in total GSH levels in cytosolic, 
mitochondrial, and whole cell fractions. We also measured the subcellular GSH:GSSG 
redox state by utilizing targeted in vivo redox sensors in mia40 mutants and found that 
Mia40 mutations solely impact the IMS GSH:GSSG redox state. Additionally, we found 
a decrease in Gsh1 expression level in mia40 mutants, when Mia40 is not functional. 
Nonetheless, we wanted to reveal whether Mia40 plays a role in iron homeostasis, which 
is dependent on iron-sulfur (Fe-S) cluster assembly. We monitored iron homeostasis by 
transforming a FET3-LacZ reporter vector into the mia40 mutants. Expression of the 
iron-uptake gene FET3 is not altered with and without GSH addition in mia40 mutants 






 Proteins in the IMS have diverse functions such as mitochondrial respiration, 
transport of proteins, metal ions, metabolites, and lipids between membranes, and 
apoptosis. Most IMS proteins lack N-terminal targeting signals and are nuclear-encoded, 
synthesized in the cytosol, and directed into the IMS on a unique import pathway 
differing in several aspects from the matrix-targeting pathway. IMS proteins containing 
conserved twin CX3C and CX9C motifs play important roles in protein transport of 
hydrophobic membrane proteins, assembly of cytochrome c and copper loading (Hell K 
2008 and Kawamata H et al 2008). Import of these proteins is performed by a 
mitochondrial disulfide relay system consisting of the import receptor Mia40 and the 
sulfhydryl oxidase Erv1 (Herrmann JM et al 2012). Both proteins are highly conserved in 
eukaryotes and essential for viability in yeast. Conditional Mia40 and Erv1 temperature-
sensitive mutants exhibit severe defects in mitochondrial biogenesis (Becher D et al 
1999, Lisowsky T 1994, and Chacinska A et al 2004). In yeast, Mia40 is synthesized as a 
precursor with a mitochondrial targeting signal and a sorting domain, imported into 
mitochondria via the TOM and TIM23 complexes and gets anchored at the inner 
membrane via its N-terminal targeting signal (Chacinska A et al 2004). In mammalian 
cells, Mia40 is not anchored to the inner membrane due to lack of an N-terminal 
extension and is soluble in the IMS (Hofmann S et al 2005). 
Mia40 can bind directly to imported substrate proteins in the IMS and acts as an 
import receptor. It has six conserved cysteine residues including a redox-active CPC 
motif, and two structural disulfides consisting of twin CX9C motifs (Figure 3.1) (Banci L 












Figure 3.1 Schematic diagram of Mia40 structure. Mia40 contains a helix-loop-
helix domain stabilized by two structural disulfide bonds. It has a short helical region 
including the redox-active CPC motif that has to be in an oxidized state to oxidize its 
substrates. In addition, the substrate proteins contain a MISS motif able to bind to the 
hydrophobic groove formed by the helix-loop-helix domain of Mia40 (Herrmann JM 




the IMS occurs through the TOM complex. Mia40 promotes disulfide bond formation 
and oxidative folding of the imported precursors by forming transient intermolecular 
disulfides with its substrate proteins. Release of substrate proteins from Mia40 is 
performed and oxidative folding traps the substrates in the IMS. Moreover, reduced 
Mia40 is reoxidized by Erv1 transferring electrons to cytochrome c and finally to oxygen 
(Böttinger L et al 2012). The Mia40-Erv1 import machinery cooperates with the TOM 
complex and MICOS (MItochondrial contact site and Cristae Organizing System), which 
brings Mia40 close to the TOM complex in order to accelerate protein folding (von der 
Malsburg K et al 2011 and Zerbes RM et al 2012). Mia40 also mediates the oxidation of 
proteins that are further imported into the matrix via the TIM23 complex or into the inner 
membrane (Wrobel L et al 2013 and Longen S et al 2014), as well as the oxidation of 
larger and more complex substrate proteins such as Atp23 and Tim22 (Weckbecker D et 
al 2012 and Wrobel L et al 2013). In addition, glutathione (GSH) affects the Mia40 redox 
state and hence protein import by assisting Mia40-mediated substrate oxidation (Bien M 
et al 2010, Kojer K et al 2012, and Kojer K et al 2015). However, it is not clear how 
Mia40-Erv1 function impacts GSH metabolism and the GSH:GSSG redox state in the 
IMS and other compartments. 
In addition to its role in IMS protein import, Mia40 is also suggested to influence 
Fe-S cluster assembly in vitro. Banci L et al showed Mia40-dependent import of the 
human version of Dre2 (anamorsin) into the intermembrane space (Banci L et al 2011). 
Dre2 is a Fe-S protein localized in the IMS and was proposed to possess two Fe-S 
clusters in its C-terminal domain containing two conserved cysteine motifs (Zhang Y et 
al 2008). It cooperates with the diflavin oxidoreductase, Tah18 by forming an electron 
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transfer chain that is essential for the assembly of cytosolic and nuclear Fe-S proteins 
(Netz DJ et al 2010). Mia40 oxidizes a twin CX2C motif of the C-terminal domain of 
anamorsin and interacts with anamorsin through an intermolecular disulfide-bonded 
intermediate (Banci L et al 2011). In addition, overexpressed Mia40 was shown to bind 
iron in vivo, while Fe–S-containing Mia40 is not an electron donor for Erv1 (Spiller MP 
et al 2013). Because recombinant human Mia40 might bind iron or an ISC in vitro 
(Daithankar VN et al 2009), it was speculated that Mia40 might coordinate an Fe-S 
cluster in the intermembrane space. On the contrary, a recent study indicated that Dre2 is 
not localized to IMS, but associates with the cytosolic surface of mitochondria and 
contains only reduced thiol residues and no disulfide bonds. Additionally, yeast Dre2 
does not interact with Mia40 in vivo or in vitro, and when it is mixed with purified Mia40 
in vitro, it is not oxidized (Peleh V et al 2014). Th fiesendings question the role of Mia40 
as a Fe-S protein important for cytosolic Fe-S cluster assembly.  
Two mia40 temperature sensitive mutant (mia40-3 and mia40-4) yeast cells used 
in this study grow like wild type cells at the permissive temperature (24 ˚C), but were 
strongly impaired at the non-permissive temperature (37 ˚C) on fermentable media 
(glucose) and were unable to grow on nonfermentable media (glycerol) at 37 ˚C 
(Chacinska A et al 2004). The mutant protein Mia40-3 is defective in its interaction with 
the precursors of small Tim proteins, which results in decreased amounts of Tim proteins. 
The mutant protein Mia40-4, however, is able to bind the precursors of small Tim 
proteins, and the precursor proteins are translocated into the IMS. However, as precursor 
proteins accumulate in this mia40-4 mutant, assembly of the small Tim proteins into the 
mature TIM complexes is postponed (Chacinska A et al 2004).  
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 In this chapter, we wanted to demonstrate the effects of Mia40 on GSH 
metabolism to reveal their roles in thiol-disulfide equilibrium. We were also interested in 
whether mutations in Mia40 have an effect on the redox homeostasis in the IMS using the 
fluorescent protein-based redox sensor, rxYFP. Moreover, we wanted to show whether 
Mia40 plays a role in iron homeostasis. Based on our findings, disruption of Mia40 
specifically impacts the IMS GSH:GSSG pool, but not matrix and cytosol GSH:GSSG 
redox balance. Furthermore, Mia40 mutations do not alter total GSH levels in the cell and 
do not impact iron regulation. 
EXPERIMENTAL PROCEDURES 
Yeast Strains, Media, and Growth Conditions— S. cerevisiae strains used in this study 
were WT strain YPH499 (MATa, ade2-101, his3-Δ200, leu2-Δ1, ura3-52, trp1-Δ63, lys2-
801) and the mutant strains mia40-3 (MATa, ade2-101, his3- Δ200, leu2-Δ1, ura3-52, 
trp1-Δ63, lys2-801, mia40::ADE2 [pFL39-FOMP2-8ts/mia40-3]), mia40-4 (MATa, 
ade2-101, his3-Δ200, leu2-Δ1, ura3-52, trp1-Δ63, lys2-801, mia40::ADE2 [pFL39-
FOMP2-7ts/mia40-4]) obtained from Dr. Agnieszka Chacinska (Institut fur Biochemie 
und Molekularbiologie, ZBMZ and Centre for Biological Signalling Studies  (BIOSS), 
Universitat Freiburg, 79104 Freiburg, Germany). Yeast transformations were performed 
by the lithium acetate pro cedure (Gietz RD et al 1995). Strains were grown on synthetic 
complete medium (SC) supplemented with 2% glucose and the appropriate amino acids 
overnight at 24 ºC, and one set was shifted to 37 ºC and grown for 5 more hours.  
Plasmids- rxYFP sensors used in this study included pHOJ150 (cytosol-rxYFP LEU2-
YIp) pJH200 (IMS-rxYFP LEU2-YIp) and pLD206 (matrix-rxYFP LEU2-YIp) are 
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described before (Hu, 2010). The FET3-lacZ reporter construct pFC-W (pDW840) that 
contains the FET3 iron-response element in a minimal promoter is described before 
(Yamaguchi-Iwai et al, 1996). 
Subcellular Fractionation- Yeast cells were grown aerobically to mid-log phase in 
selecting SC medium with 2% glucose. Mitochondrial and post-mitochondrial 
supernatant (PMS) fractions were obtained as previously described by converting cells to 
spheroplasts followed by gentle lysis by Dounce homogenization and differential 
centrifugation (Daum G et al 1982). 
Glutathione Assay- Total glutathione was measured by the DTNB-GR (glutathione 
reductase) recycling assay as described previously (Outten CE 2004). 
GSH Assay by using the GSH/GSSG-GloTM Kit- Whole cell GSH was measured by 
GSH/GSSG-GloTM Kit (Promega, USA) following the manufacturer’s protocol with 
slight modifications. 4-5×105 cells were harvested by centrifugation and suspended in 
lysis buffer, supplied by the kit. Whole cell extracts were prepared through mechanical 
disruption using glass beads. Based on the manufacturers’ indications, desired reactions 
were performed and stable luciferin luminescent signals were detected using a Synergy 
H1 Hybrid Multi-Mode Microplate Reader (Biotek, USA). The luminescent signals were 
proportional to the amount of GSH and correlated with the total cell amount. The results 
are expressed in nmol GSH per 107 cell. 
Redox Western- Redox western blot analysis of rxYFP and Mia40 was measured as 
previously described (Hu J et al 2008). Cells were grown in SC media to mid-log phase 
and then acid-quenched with trichloroacetic acid (Sigma) (15% (w/v) final concentration) 
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at 4 °C for 20 min. Five A600 units of cells were harvested by centrifugation and 
resuspended in 1 ml of 10% trichloroacetic acid. Following glass bead lysis, the lysed 
cells were transferred to a new tube and pelleted by centrifugation. The pellet was 
resuspended in 500 μl of 1X non-reducing SDS sample buffer containing 40 mm N-
ethylmaleimide (Sigma). Following a 10-min incubation at room temperature, the 
proteins were separated on a 16% Tris-glycine gel (Invitrogen). Reduced and oxidized 
forms of rxYFP and Mia40 were analyzed by quantitative immunoblot using an Odyssey 
Infrared Imaging System (LI-COR). 
Immunoblotting Techniques- Cytosolic and mitochondrial fractions were subjected to 
electrophoresis on Tris-glycine gels (Invitrogen) and analyzed by western blotting using 
an anti-Erv1 (kind gift of J.Riemer) (1:10000 dilution) or anti-Gsh1 (kind gift of J. 
Barycki) (1:10000 dilution) antibody, and a secondary anti-rabbit IgG (IRDye, LI-COR 
Lincoln, NE) (1:25000 dilution). Cytosolic fractions were monitored by an anti-3-
phosphoglycerate kinase (Pgk1) (1:10000 dilution) antibody (Invitrogen). Mitochondrial 
fractions were monitored using an anti-Porin antibody (Invitrogen) (1:12500 dilution). 
Proteins were analyzed by western blot using an Odyssey Infrared Imaging System (LI-
COR). Protein concentrations were determined using the Bradford method (Bio-Rad) 
with bovine serum albumin as the calibration standard. 
β-galactosidase Assays—mia40 strains tested were transformed with the FET3-lacZ 
reporter construct pFC-W that contains the FET3 iron-response element in a minimal 
promoter (Yamaguchi-Iwai et al, 1996). Temperature-sensitive mia40 and corresponding 
parent strain were grown in selecting SC glucose media at 24 °C to an OD600 of 1 and 
then divided into 3-ml aliquots for induction.  The cultures were incubated at 24 and 37 
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°C with either 50 μM FeCl3 (high Fe), 100 μM bathophenanthroline disulfonate (BPS) 
(low Fe), or no addition (normal Fe) for 5 hours.  GAL-ERV1 and the parent W303A 
strain were grown for 64 hours at 30 °C to an OD600 of 1 in inducing (SC 
raffinose/galactose) or repressing (SC-raffinose) media and were divided similarly into 
high, low, and normal Fe aliquots and grown for an additional 4 hours at 30 °C.  Cells 
were then harvested and assayed for β-galactosidase activity as previously described 
(Thorvaldsen et al, 1993). 
RESULTS 
Changes in Mia40 redox state and Erv1 protein levels in mia40 mutants. A recently 
identified disulfide relay system in the mitochondrial intermembrane space, including the 
sulfhydryl oxidase Erv1 and import receptor Mia40, is affected by GSH, which 
accelerates the oxidation between Mia40 and its substrates in vivo and in vitro. On the 
other hand, it is not known how the disruption of this pathway affects the redox state of 
the IMS and nearby compartments. In order to investigate this, we used two different 
mia40 temperature sensitive mutants (mia40-3 and mia40-4) that contain several point 
mutations generated by error-prone PCR and are isolated by screening for a temperature-
sensitive growth phenotype. The mutations led to the following amino-acid changes for 
mia40-3: K100R, E142G, E144A, D178G, M361V, E370Stop and for mia40-4: T313A, 
I316M, F342L. First of all, similar to what we did in Chapter 2, the redox state of Mia40 
was measured in mia40 strains to confirm the defect of Mia40 oxidation at 37 °C. Mia40 
has a redox-active cysteine motif that has to be in an oxidized state to oxidize its 
substrates. Mutations in Mia40 result in reduction of this disulfide bond. We grew the 
mia40 strains overnight at the permissive temperature (24 °C) as described in Chapter 2 
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and then switched them to the restrictive temperature (37 °C) for 5 hours to impair Mia40 
function. When we measured Mia40 redox state in these mia40 mutants, we observed the 
reduced Mia40 at 37 °C in these strains which confirms the Mia40 defect (Figure 3.2). 
We also observed the faster mobility on SDS-PAGE for mia40-3 strain. The reason is 
that a stop codon in the mia40-3 allele caused a C-terminal truncation of Mia40-3 and a 
faster mobility on SDS–PAGE than the wild-type protein (Chacinska A et al 2004). 
Second, we tested Erv1 protein expression levels in mia40 strains as an additional 
confirmation study. Disruption of Mia40 function will lead to defects in Erv1 import and 
consequently, reduced amount of Erv1 in the IMS. We performed reducing SDS-PAGE 
to test the expression level of Erv1 protein in mitochondrial fractions of mia40 strains and 
found that Erv1 expression is mostly reduced in mitochondria at the restrictive 
temperature (37 °C) as expected (Figure 3.3). Based on these findings, we conclude that 
mia40 temperature-sensitive mutants possess defective Mia40 when grown at 37 °C.  
Disruption of Mia40 leads to a more reducing IMS redox state and no significant 
changes on iron homeostasis. In order to uncover the mechanism of the connection 
between Mia40 and GSH metabolism and their impact on subcellular compartments, we 
measured total GSH levels and the GSH:GSSG redox state in mia40 strains. We 
expressed cytosol-, IMS-, or matrix-rxYFP in mia40 temperature-sensitive mutants. 
Redox western results utilizing the targeted rxYFP redox sensors demonstrated that 
mutations in Mia40 function cause a more reduced GSH:GSSG redox state in the IMS 
compared to the WT strain (Figure 3.4-A). The matrix-rxYFP and cytosol-rxYFP redox 
states of the mia40 strains are similar to the WT strain at both the permissive and 
restrictive temperatures (Figure 3.4B-C). Thus, we observed that mutations in Mia40 
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impact the GSH:GSSG redox state in IMS; however, the effect varies depending on the 
specific mutation. We then performed total GSH assays to confirm the redox western 
data. Total GSH levels of cytosolic and mitochondrial fractions in mia40 strains are 
similar to the WT strain at both temperatures (Figure 3.5A-B). In addition, we measured 
whole cell GSH in these mia40 strains and found no significant changes in total GSH 
levels between WT and mia40 strains (Figure 3.5-C). We also checked Gsh1 protein 
expression levels in mia40 strains and found that when Mia40 is defective at the 
restrictive temperature (37 °C), Gsh1 expression levels are decreased by ~2 fold 
compared to WT in both mia40 mutants (Figure 3.6). It would be interesting to check 
mRNA levels of GSH1 in mia40 strains to examine whether Mia40 dysfunction also 
impacts GSH1 gene expression. Therefore, we conclude that Mia40 malfunction has no 
effect on cellular GSH levels and only influences the IMS GSH:GSSG redox state.  
 As we mentioned in the introduction of this Chapter, Mia40 was proposed to 
serve as a Fe-S protein and thus may be involved in cytosolic Fe-S assembly. Adrienne 
Dlouhy from the C. Outten group measured expression of the FET3 gene via β-
galactosidase assays of mia40 mutants with and without the addition of GSH in iron-
replete and iron-limited medium. She found no significant changes in FET3 expression in 
low iron media with and without the addition of GSH (Figure 3.7). Since mia40 mutants 
did not show FET3 activation under high and low iron conditions, we conclude that 












Figure 3.2 In vivo Mia40 redox state measurements in mia40 temperature 
sensitive mutants. Redox western blots were performed on mia40 strains and blots 
were immunoblotted with α-Mia40 antibody. Reduced and oxidized forms of Mia40 
were quantified using an Odyssey Infrared Imaging System. The reported values are 
the mean of 3-4 independent experiments. Error bars are the means + standard 
















Figure 3.3 Mitochondrial Erv1 protein levels in mia40 strains. WT and mia40 
strains were grown in SD glucose media at 24 ºC and 37 ºC and were analyzed by 
SDS-PAGE and immunoblotted with α-Erv1 and α-Porin antibodies. 15 µg 





Figure 3.4 Subcellular GSH:GSSG redox state in mia40 mutants. WT and mia40 
strains were transformed with an rxYFP expression plasmid pHOJ150 (cytosol-
rxYFP), pLD206 (matrix-rxYFP), or pJH200 (IMS-rxYFP) and grown in SD (-Leu) 
glucose selection media. Redox western blots were performed on the indicated strains. 
Error bars represent the standard deviation for 3-4 independent experiments. WT(2) 





Figure 3.5 Total GSH values in cytosolic, mitochondrial and whole cell extracts 
for mia40 strains. WT and mia40 strains were grown in SD glucose media overnight 
at 24 ºC, and one set was shifted to 37 ºC and grown for 5 more hours.  The reported 
values are the mean of 4-5 independent experiments. Error bars are the means + 












Figure 3.6 Gsh1 protein levels in mia40 mutant cells. WT and mia40 strains were 
grown in SD glucose media at 24 °C overnight and one set was shifted to 37 °C for 5 
hours. Cytosolic fractions were isolated and used for the western blot. Pgk1 was 
used as a loading control with 75 µg cytosolic protein. Gsh1 and Pgk1 bands were 
quantified using an Odyssey Infrared Imaging System and relative to control ratio 
was calculated. The reported values are the mean of at least 3 independent 































Figure 3.7 Expression of the Aft1/2-regulated gene FET3. WT and mia40 strains 
were transformed with a FET3-LacZ reporter plasmid and grown at 24 or 37 °C in SC 
glucose media. β- galactosidase activity was measured for cells grown in medium 
supplemented with iron (high Fe), no iron (normal Fe), or the iron chelator BPS (low 
Fe) ± 1 mM GSH. Error bars indicate standard deviation for 3-5 independent 




 In this study, the redox state of Mia40 in vivo was analyzed for mia40 strains to 
confirm their defects. Mia40 exists in a mixture of oxidized (∼80%) and reduced (∼ 
20%) forms in vivo for WT and mia40 strains when Mia40 is functional. Our result is 
consistent with a recent study by Kojer et al 2012 in which approximately 70% of Mia40 
CPC was oxidized in vivo in WT strain. However, mutations on Mia40 lead to reduced 
Mia40 (~25-45%) at the restrictive temperature (37 °C) as expected. Since Mia40 is 
required for the import of Erv1 into the IMS, as another confirmation study, we analyzed 
Erv1 expression in mitochondrial fractions of mia40 strains. The steady-state level of 
Erv1 was significantly reduced when mia40 strains were grown at elevated temperature 
which is consistent with earlier findings that mia40 mutants contain reduced levels of 
substrate proteins such as small Tim proteins (Chacinska A et al 2004 and Bragoszewski 
P et al 2013).  
 We have also established that Mia40 dysfunction does not influence the redox 
state of matrix or cytosol, but impacts the IMS redox state demonstrated by utilizing 
organelle-targeting rxYFP sensors. As we have shown in Chapter 2, mutations on Erv1 
caused the reduction in oxidized rxYFP ratio in the IMS. Similarly, defects on Mia40 led 
to a more reduced IMS redox state. The mutant protein Mia40-3 is defective in its 
interaction with Mia40 due to impaired formation of Mia40 intermediate with substrate 
proteins, as a consequence, impaired import of the precursors into the IMS. The mutant 
protein Mia40-4, however, is able to efficiently bind the precursor proteins, but is 
impaired in their release (Chacinska A et al 2004), hereby mia40 mutations inhibit the 
oxidation of substrates in the IMS.  
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In this study, we maintained reduced IMS GSH:GSSG redox state by using rxYFP, which 
relies on the availability of endogenous dithiol glutaredoxins for the rapid and complete 
equilibration with the surrounding glutathione pool in mia40 mutants. Previously, our lab 
found that an IMS‐targeted version of rxYFP was more oxidized than its respective 
cytosolic and matrix variants (Hu J et al 2008). Recently published study pointed out the 
presence of limiting availability of glutaredoxins in the IMS (Kojer K et al 2015). When 
endogenous glutaredoxin availability or activity is limiting, then rxYFP may become 
oxidized by other sources such as ROS from the respiratory chain and thus lose its ability 
to serve as a specific reporter for the glutathione redox couple. Therefore, unfused probes 
rxYFP sense the redox environment the same way proteins thiols do. In the IMS, rxYFP 
behaves similar to a substrate protein that is influenced primarily by the Mia40-Erv1 
system and not by GSH:GSSG since there is limiting Grx available to allow equilibration 
with GSH:GSSG. Thus, Mia40 dysfunction leads to reduced rxYFP response in the IMS. 
In addition, in this study, we demonstrated that any defects on Mia40 did not impact total 
GSH levels in mitochondria, cytosol, or whole cell.  
 We also observed decreased Gsh1 expression, but no change in total GSH levels 
when Mia40 is not functional. So far, there is no study to show the link between Mia40 
and Gsh1. The reason of the decrease in Gsh1 expression might be changes at the 
transcriptional or post-transcriptional level. In addition, post-translational changes such 
as degradation or ubiquination might lead to reduced protein turnover and, eventually 
reduced protein synthesis (Lu SC 2009). However, Mia40 dysfunction does not result in 
lower total GSH levels. The reasons for the normal level of total GSH are following: First 
of all, decreased Gsh1 expression might activate Yap1 transcription factor that 
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upregulates Gsh2 catalyzing the second step of GSH synthesis which hereby normalizes 
cellular GSH levels (Lu SC 2009). Second, decreased Gsh1 expression might increase the 
rate of Gsh1 enzymatic reaction by increasing the substrate cysteine uptake whose 
availability regulates Gsh1 activity (Tateishi N et al 1974). 
 Mia40 has been also shown to bind iron when overexpressed in vivo and to 
assemble a Fe-S cluster in vitro (Spiller MP et al 2013). Moreover, it was speculated that 
Mia40 might coordinate a Fe/S cluster in the IMS, but the existence of such a cofactor for 
this function in vivo is still missing. In Chapter 1, we showed that Erv1 is not involved in 
extramitochondrial Fe-S protein maturation and iron regulation. Similarly, measurements 
of the expression of the Aft1-regulated iron-uptake gene, FET3, performed by Adrienne 
Dlouhy demonstrated that FET3 expression does not change under low iron conditions in 
mia40 strains suggesting that Mia40 plays no significant role in iron homeostasis since 
impairment of mitochondrial Fe-S cluster biogenesis and export activates the FET3 
expression (Outten CE et al 2013). Previously, yeast Dre2 and its human homolog, 
Anamorsin, components of the cytosolic iron sulfur (Fe-S) assembly machinery and their 
interaction with Mia40 in the IMS were documented (Banci L et al 2011). Purified Mia40 
was able to oxidize anamorsin in vitro (Banci L et al 2011), by introducing two disulfide 
bonds into a domain suggested to serve as a Fe-S binding region (Zhang Y et al 2008). 
Based on this, they conclude that anamorsin/Dre2 was the first identified Fe-S protein 
imported into the IMS, and might play a role in cytosolic Fe-S biogenesis. On the other 
hand, recently published study indicates that Dre2 does not interact with Mia40 in vivo or 
in vitro, contains only reduced thiol residues and no disulfide bonds and is not oxidized 
when mixed with purified Mia40 in vitro (Peleh V et al 2014). Interestingly, they showed 
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that Dre2 is not localized to IMS, but bounds to the cytosolic side of the outer membrane 
of mitochondria excluding the role of Mia40 in this process (Peleh V et al 2014). This 
study suggests that there is no redox modification of the cysteine residues of Dre2 in vivo 
by Mia40 or no coordination of a Fe/S cluster in the mitochondrial intermembrane space. 
Our data also supports these findings. No Aft1 activation seen in mia40 mutants suggests 
that Mia40 is not involved in iron regulation. Moreover, the Fe-S cluster in Mia40 may 
still be physiologically relevant as shown before, but not involved in Fe-S cluster 















DELETION OF MITOCHONDRIAL CARRIER PROTEINS, MTM1 AND YHM2 AFFECTS 












The mitochondrion has several distinct functions such as oxidative 
phosphorylation, Fe-S clusters and heme biosynthesis, and biosynthesis of lipids, amino 
acids, and nucleotides. These metabolic pathways are all dependent on cysteine-
containing proteins. Therefore, maintaining thiol-disulfide redox balance in this organelle 
is critical for cellular functions. Intracellular redox homeostasis is mainly controlled by 
the reduced and oxidized forms of glutathione (GSH and GSSG), which serve as an 
intracellular redox buffer. To investigate the factors that affect the mitochondrial 
GSH:GSSG redox state, we used genetically modified in vivo redox sensors roGFP2 and 
Grx1-roGFP2 (green fluorescence protein and glutaredoxin-fused green fluorescence 
protein). Both sensors equilibrate with GSH:GSSG pools via disulfide bond formation. 
Utilizing the roGFP2 in vivo sensors, we demonstrate how the deletion of manganese 
cofactor of superoxide dismutase 2, (Mtm1) and citrate-oxoglutarate carrier (Yhm2) 
affect the redox status of the mitochondrial matrix and intermembrane space (IMS). We 
have found that deletion of the MTM1 leads to a large oxidative shift in the IMS 
GSH:GSSG redox state, with little change in the matrix GSH:GSSG redox state. 
Moreover, deletion of YHM2 shows a smaller influence on the mitochondrial GSH:GSSG 
redox state under the same conditions. However, both mtm1∆ and yhm2∆ mutants were 
shown to have decreased mitochondrial GSH levels. Overall, these results indicate that 
reduction in mitochondrial GSH levels in mtm1∆ and yhm2∆ mutants impact 





Mitochondria perform diverse functions such as respiration, energy metabolism, 
synthesis of amino acids, membrane phospholipids, Fe-S clusters and heme. 
Mitochondria also provides a network for cell signaling and regulation. On the other 
hand, metabolic exchange and chemical trafficking is severely restricted between the 
mitochondrial matrix and the cytoplasm. The mitochondrial outer membrane possesses 
non-selective pores (porins or voltage-dependent anion channel (VDAC)) and is freely 
permeable to molecules below ~ 5 kDa such as sucrose, adenine nucleotides, Coenzyme 
A, and tRNA. However, the mitochondrial inner membrane transports metabolites based 
on driving forces and substrate specificity (Wohlrab H 2009). A nuclear-encoded 
superfamily of secondary transport proteins called mitochondrial carriers (MCs) catalyze 
the translocation of several metabolites, nucleotides and coenzymes across the inner 
membrane of mitochondria and provide a connection between metabolic reactions of the 
cytosol and mitochondrial matrix. The members of this carrier family are widespread in 
eukaryotes and share common sequence features such as a tripartite structure, six 
transmembrane α-helices and a 3-fold repeated signature motifs (Kunji ERS et al 2004). 
Mitochondrial carrier proteins function in several distinct metabolic pathways, such as 
oxidative phosphorylation, citric acid cycle, fatty acid oxidation, amino acid degradation, 
gluconeogenesis, transfer of reducing equivalents, synthesis and breakdown of 
mitochondrial DNA, RNA, and proteins, heme biosynthesis, modulation of the nucleotide 
and deoxynucleotide pools in the mitochondrial matrix, and apoptotic cell death (Palmieri 
F et al 2013). In yeast, 35 mitochondrial carrier proteins (MCPs) have been identified by 
genome analysis (Palmieri L et al 2000).  
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Mtm1 is a one of the mitochondrial carrier proteins localized in the mitochondrial 
inner membrane. Initially, it was identified as a Manganese Trafficking factor for 
Mitochondrial Superoxide dismutase (Sod2) and proposed that to function as a 
manganese chaperone (Luk E et al 2003). However, later on, this function was revised 
since Mtm1 plays a role in mitochondrial Fe–S cluster biosynthesis and iron homeostasis. 
First of all, it was shown that mtm1 deletion results in the inactivation of Sod2, while   
Sod2 activity is restored in mtm1Δ mutants by adding back manganese into the growth 
media. However, mtm1∆ mutants have no manganese depletion phenotype and 
conversely, they show a slight increase in the amount of mitochondrial manganese (Luk 
E et al 2003). Furthermore, interestingly, elevated iron levels were found in mtm1∆ 
mitochondria. Another paper published by the same group also demonstrated that 
decreased Sod2 protein activity in mtm1∆ mutants is because of misincorporation of iron 
into Sod2 protein rather than manganese. Therefore, as iron homeostasis is impaired in 
the case of inactivation of Mtm1, this leads to iron accumulation in a reactive form in 
mitochondria which likely competes with manganese for binding to Sod2, and inactivates 
the enzyme in yeast cells (Yang M et al 2006). In addition, Mtm1 depletion caused the 
activation of the iron regulator Aft1 but no major defects on cytosolic Fe-S protein Leu1 
(isopropylmalate isomerase) and mitochondrial Fe-S protein Aco1 (Aconitase). This 
study suggested that deactivation of Mtm1 may change the levels of a particular 
metabolite within the mitochondrial matrix that helps to stabilize iron in a bioavailable 




Another mitochondrial inner membrane carrier protein, Yhm2 was identified as a 
multicopy suppressor of temperature-sensitive growth defect displayed at 37 °C by cells 
lacking ABF2, which is involved in mitochondrial DNA replication and recombination. It 
was shown that YHM2 is associated with mitochondrial DNA in vivo and shows general 
DNA-binding activity in vitro (Cho JH et al 1998). Later on, the Palmieri lab 
characterized Yhm2 as a citrate-oxoglutarate carrier protein. In addition to transporting 
citrate and oxoglutarate, Yhm2 can also transport oxaloacetate, succinate, and fumarate to 
a lesser extent, but not malate and isocitrate (Castegna A et al 2010). Furthermore, they 
showed that yhm2∆ cells have a growth defect upon exposure to hydrogen peroxide, 
decreased cytosolic NADPH/NADP+ and GSH/GSSG ratios as well as an increased 
NADPH/NADP+ ratio in mitochondria. Based on these findings, it was proposed that a 
primary physiological function of Yhm2 is to increase the cytosolic NADPH reducing 
power that is essential for thiol-dependent peroxidases and to serve as an important 
component of the citrate-oxoglutarate NADPH redox shuttle between the cytosol and 
mitochondria (Castegna A et al 2010).  
In mammalian cells, two members of the superfamily of anion carriers in the 
mitochondrial inner membrane, dicarboxylate carrier (DIC) and 2-oxoglutarate carrier 
(OGC) that is the mammalian homolog of Yhm2 have been shown to catalyze uptake of 
GSH into the matrix in rat renal cortex cells (Chen Z et al 1998). Because GSH is a 
negatively charged molecule at physiological pH, anion carriers in the mitochondrial 
inner membrane, DIC and OGC might be good candidates for transporting GSH. The 
same group also showed that DIC and OGC carriers can transport cytoplasmic GSH into 
the mitochondrial matrix in rat kidney cortex cells (Chen Z et al 2000). Moreover, OGC 
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has shown to interact with the central regulator of the intrinsic apoptotic cascade Bcl-2 to 
increase the mitochondrial GSH pool in primary cerebellar granule neurons (Wilkins HM 
et al 2012). The Linseman group also pointed out that overexpression of OGC in motor 
neuronal cells resulted in an increase in mitochondrial GSH and increased resistance to 
oxidative stress (Wilkins HM et al 2014). On the contrary, the Murphy group showed that 
overexpression of the dicarboxylate and 2-oxoglutarate carriers in Lactococcus lactis 
cells did not lead to GSH uptake or transport since excess GSH had no effect on the 
transport rate of substrates (Booty LM et al 2015).  
Here we show that the deletion of MTM1 leads to lower mitochondrial GSH 
levels and large shift in the IMS redox state. However, deletion of YHM2 influences 
mitochondrial redox status in a smaller extent and leads to decrease in mitochondrial 
GSH levels. Dysfunction of these two proteins impact GSH:GSSG pools in mitochondria, 
and this impact varies in mtm1∆/yhm2∆ mutants depending on their specific transporter 
functions.  
EXPERIMENTAL PROCEDURES 
Yeast Strains, Media, and Growth Conditions— Saccharomyces cerevisiae strains used 
were BY4741 (MATa his3∆1 leu2∆0 met15∆0 ura3∆0), yhm2∆::kanMX4, and 
mtm1∆::kanMX4 obtained from Open Biosystems. Yeast transformations were performed 
using the lithium acetate procedure. Strains were maintained at 30 °C on synthetic media 
(SC) supplemented with 2% glucose with the appropriate amino acids. 
Plasmids— roGFP2 sensors used in this study included pZX201 (cytosol-roGFP2 LEU2-
YIp) (Xue, 2011), pJH602 (IMS-roGFP2 LEU2-YIp) (Hu, 2010) and pJH601 (matrix-
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roGFP2 LEU2-YIp) (Hu, 2010). IMS Grx1-roGFP2 (p416-b2-Grx1-roGFP2, URA3-
CEN), matrix Grx1-roGFP2 (p416-Su9-Grx1-roGFP2, URA3-CEN), and cytosol Grx1-
roGFP2 (p416-Grx1-roGFP2, URA3-CEN) were obtained from Jan Riemer (Universität 
Kaiserslautern, Germany).  
Cytosolic and mitochondrial GSH measurements— Yeast cells were grown aerobically 
to mid-log phase in YP medium with 2% galactose. Mitochondrial and post-
mitochondrial supernatant (PMS) fractions were obtained as previously described by 
converting cells to spheroplasts followed by gentle lysis by Dounce homogenization and 
differential centrifugation (Daum G et al 1982). Total GSH was measured by 
GSH/GSSG-GloTM Kit (Promega, USA) following the manufacturer’s protocol with 
slight modifications. 1:20 dilution for PMS extracts (5µl extract for the assay) and 1:5 
dilution for mitochondrial extracts (10µl extract for the assay) were used. See Chapter 5 
for the detailed protocol. This assay was performed by C. Outten group member Dr. 
Vidyadhar Daithankar.  
Redox Western Technique- See Chapter 1. 
RESULTS 
Deletion of Mtm1 affects the redox state of the IMS. In order to identify membrane 
transporters that influence GSH levels in mitochondria, our lab member, Dr. Vidyadhar 
Daithankar, screened strains containing deletions of mitochondrial membrane transport 
genes from our collection of yeast deletion strains (Open Biosystems). These mutants 
include the VDAC homologues, outer membrane TOM proteins and inner membrane 
TIM proteins, members of the mitochondrial carrier family (including the yeast 
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homologues of OGC and DIC), ATP-binding cassette transporters, and P-type ATPases. 
Based on this screen, he found that mtm1∆ and yhm2∆ mutants have decreased levels of 
GSH in mitochondria (Figure 4.1-B). Since the human homolog of Yhm2 has been 
shown to transport GSH into the mitochondrion, we wanted to determine how mtm1∆ and 
yhm2∆ mutants containing significantly low GSH in their mitochondria influence the 
subcellular GSH:GSSG redox state in the cytosol, mitochondrial matrix, and IMS using 
the modified fluorescence protein roGFP2 and glutaredoxin (Grx)-fused roGFP2 sensors. 
In order to observe the redox state of roGFP2, the free thiols were capped with N-
ethylmaleimide (NEM) to prevent oxidation during sample preparation. The reduced and 
oxidized proteins have different mobilities by non-reducing SDS-PAGE, thus, the relative 
ratio of oxidized to reduced roGFP2 was determined. Even though mtm1∆ and yhm2∆ 
cells have considerably low GSH levels in mitochondria, the matrix GSH:GSSG redox 
state measured in these mutants by using roGFP2 and Grx1-roGFP2 sensors was not 
more oxidized. It is reasonable to expect a more oxidized GSH:GSSG redox state in the 
matrix due to low mitochondrial GSH seen in mtm1∆ and yhm2∆ cells since the 
mitochondrial matrix constitutes the major portion of the mitochondrial volume. We 
observed a large difference in the IMS redox state when MTM1 was deleted. IMS-
roGFP2 is more oxidized in mtm1∆ cells (41% oxidized compared to 6% oxidized for 
WT), but no significant differences were measured in matrix and cytosol roGFP2 (Figure 
4.2-B). However, it is interesting to note that roGFP2 is not well as expressed in the 
matrix and IMS in mtm1∆, making it difficult to get a reliable reading (Figure 4.2-A). In 
contrast, there is a little change in the IMS, matrix and cytosol roGFP2 responses upon 
deletion of the YHM2 gene (Figure 4.2-B).  
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We also performed redox measurements using Grx1-roGFP2 sensors since these 
sensors equilibrate more rapidly with GSH:GSSG pools in subcellular compartments 
such as the IMS that do not contain GRXs (Meyer A et al 2010). Consistent with the 
roGFP2 response in mtm1∆ and yhm2∆ cells, we found that only mtm1∆ possesses a 
highly oxidized IMS GSH:GSSG redox state (20.6% oxidized Grx1-roGFP2 compared to 
7.5% oxidized for WT) versus yhm2∆ strain and its corresponding WT (Figure 4.3-B). 
However, when the YHM2 gene was deleted, we did not observe a difference in the % 
oxidized IMS and cytosol Grx1-roGFP2, but found a slight increase in the matrix 





Figure 4.1 Total GSH values in cytosolic and mitochondrial extracts of mtm1∆ 
and yhm2∆ strains. WT, mtm1∆ and yhm2∆ strains were grown in 5 ml YPGalactose 
media overnight at 30 ºC until mid-log phase and this overnight culture was 
reinoculated into 50 or 100 mL YPGalactose media until they reach mid-log phase. 
The reported values are the mean + standard deviation of 2-5 independent 

























Figure 4.2 roGFP2 redox response in WT, mtm1∆, and yhm2∆ strains. WT, 
mtm1∆, and yhm2∆ yeast cells expressing cytosol (pZX201), IMS (pJH602), and 
matrix (pJH601)-roGFP2 were grown to mid-log phase in selective –Leu SC glucose 
media. (A) Redox western blot of the samples separated by non-reducing SDS-PAGE 
and immunoblotted with anti-GFP antibodies. (B) Percent oxidized roGFP2 was 
quantified using an Odyssey Infrared Imaging System. Error bars represent standard 













Figure 4.3 Grx1-roGFP2 redox response in WT, mtm1∆, and yhm2∆ strains. WT, 
mtm1∆, and yhm2∆ yeast cells expressing cytosol p416-Grx1-roGFP2, matrix p416-
Su9-Grx1-roGFP2, and IMS p416-b2-Grx1-roGFP2 were grown to mid-log phase in 
selective –Ura SC glucose media. (A) Redox western blot of the samples separated by 
non-reducing SDS-PAGE and immunoblotted with anti-GFP antibodies. (B) Percent 
oxidized roGFP2 quantified using an Odyssey Infrared Imaging System. Error bars 




As described before, the S. cerevisiae Mtm1 protein was identified as a member 
of the mitochondrial carrier family of transporters (Luk E et al 2003). mtm1∆ cells 
possess inactive Sod2 protein in the mitochondrial matrix due to misincorporation of Fe 
instead of Mn in the active site of Sod2 caused by disruption of mitochondrial iron 
homeostasis (Luk E et al 2003 and Yang M et al 2006). Dysregulation of iron 
homeostasis, in turn,  is due to accumulation of mitochondrial iron by activated of the 
iron regulator Aft1 (Yang M et al 2006). In addition, it was proposed that mtm1 
mutations affect the Fe-S cluster biogenesis pathway since this strain has similar 
phenotypes to grx5∆ and ssq1∆ mutants, including defects in Fe-S cluster synthesis 
leading to induction of the Aft1 iron regulon and high mitochondrial iron (Yang M et al 
2006), loss of Sod2 activity (Yang M et al 2006) and induction of Isu1 expression 
(Naranuntarat A et al 2009). In addition, misincorporated Fe was shown to originate from 
the Fe-S cluster donated by the Fe-S scaffold protein Isu1 (Nilsson R et al 2009). The 
Culotta group suggested that mtm1∆ cells may counteract Fe-S cluster defects by 
increasing Isu1 protein levels (Naranuntarat A et al 2009) (Figure 4.4-A). 
We found that there is an increase in % oxidized roGFP2 in the IMS in mtm1∆ 
cells grown in the fermentable carbon source glucose. In these conditions, since cells rely 
on anaerobic glycolysis for energy, mitochondrial function is repressed. However, within 
the matrix, only slight decrease in oxidized roGFP2 was observed in mtm1∆ cells with no 
change in the cytosolic roGFP2 response. Recent studies showed that glutaredoxin 
(GRX)-fused roGFP2 sensors more efficiently equilibrate with local GSH:GSSG pools. 
Fusion of GRX to roGFP overcomes kinetic limitations due to the absence of GRXs in 
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subcellular compartments (Gutscher M et al 2008 and Meyer A et al 2010). When we 
used Grx1-roGFP2 sensors, mtm1∆ cells showed mostly oxidized IMS redox state (21% 
oxidized comparing to 7% oxidized for WT) parallel to roGFP2 results suggesting that 
mtm1 deletion only impacts the IMS GSH:GSSG pool. Further studies might include 
measuring subcellular redox state under respiratory growth conditions such as growing 
the cells in media supplemented with galactose, a partially fermentable carbon source in 
which the cells are more dependent on mitochondrial function. Nevertheless, 
mitochondrial GSH levels are severely reduced in mtm1∆ cells, when the cells are grown 
in galactose-supplemented media. Contrary to mitochondrial GSH levels, mtm1∆ cells 
does not possess greater % oxidized roGFP2 in the matrix even though the redox state of 
roGFP2 is reflected by total GSH and the GSH/GSSG ratio. Therefore, GSH 
measurement studies in mtm1∆ cells suggest that the reason of the iron accumulation may 
be lower mitochondrial GSH levels in mtm1∆ cells (Figure 4.1) since mutants known to 
accumulate mitochondrial iron such as gsh1∆ or erv1-1 cells have decreased 
mitochondrial GSH with the induction of Aft1. As a mitochondrial transport carrier, 
Mtm1 exchanges a solute between the matrix and the IMS which may affect iron 
homeostasis or redox equilibrium, which may strongly influence the IMS redox state 
rather than the matrix GSH:GSSG pool. In addition, a recently published study 
demonstrated that mtm1 deletion diminishes Sod2 activity in a manner that does not 
involve Fe misincorporation.  Most of the accumulated Fe in mtm1∆ is present as FeIII 
oxyhydroxide nanoparticles, which is unlikely to misincorporate into apo-Sod2, 
suggesting an alternative cellular function for Mtm1 (Park J et al 2013). 
101 
 
Another protein that studied in this Chapter is Yhm2 serving as a citrate-
oxoglutarate carrier (Castegna A et al 2010). We found that YHM2 deletion causes a 
slight increase in the % oxidized matrix-roGFP2 sensors and no change in the response of 
cytosolic roGFP2 sensors. This might be explained by the fact that decreased level of 
mitochondrial GSH in yhm2∆ cells (Figure 4.1) causes an increase in oxidized roGFP2 
response in the matrix, but still the impact is not as significant as we expected. 
Furthermore, the mmmalian homolog of Yhm2 (OGC) was shown to transport GSH into 
the matrix and over-expression of the OGC in neuronal cells increased mitochondrial 
GSH levels and oxidative stress resistance. This is consistent with the GSH 
measurements of yhm2∆ cells suggesting Yhm2 may transport GSH into the matrix 
(Figure 4.4-B). A previous study using acetate-supplemented media for yhm2∆ cells 
showed the decreased level of cytosolic NADPH/NADP+ and GSH/GSSG ratios 
suggesting elevated levels of GSSG and decreased levels of NADPH in the cytosol. 
These effects are more apparent when cells are exposed to hydrogen peroxide (Castegna 
A et al 2010). However, we did not observe any changes in the cytosolic GSH:GSSG 
redox state or cytosolic GSH levels. Since we used glucose containing media for the 
measurements, it would be interesting to utilize acetate containing media because cells 
lacking both IDP2 and ZWF1 (i.e. major sources of cytosolic NADPH) display a 
dramatic growth defect due to increased levels of intracellular oxidants produced during 
acetate metabolism (Minard KI et al 2001 and Minard KI et al 1999).  
Taken together, our studies indicate that mtm1∆ and yhm2∆ cells affect GSH 
metabolism in mitochondria and the redox status of the IMS or mitochondrial matrix 
depending on the carbon source in the media. On the other hand, mtm1∆ mutants have the 
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largest change in IMS redox state than the other mutant yhm2∆. This effect might be due 
to fact that Mtm1 exchanges a glutathione-conjugated metabolite between the matrix and 



























Figure 4.4 Proposed model pathways for mtm1∆ and yhm2∆ cells. A) Working 
model of mitochondrial Fe-S cluster biogenesis in mtm1∆ cells. Mtm1 is involved in 
activation of mitochondrial Sod2 by facilitating insertion of essential manganese 
cofactor. Therefore, deletion of Mtm1 causes inactive Sod2. mtm1∆ cells accumulate 
high iron which is activated by iron sensing transcriptional factor Aft1. In addition, Fe 
binds Sod2 blocking late stages of iron-sulfur cluster biogenesis which is assisted by 
the upregulation of Isu1 protein level. In this study, it was shown that mtm1∆ cells 
have severely decreased level of mitochondrial GSH. Concerning its low level of GSH 
in its mitochondria, it might provide glutathione-conjugated Fe–S clusters or other 
glutathione persulfide forms to the Atm1 which helps to activate Aft1. B) Alterations 
in mitochondria of yhm2∆ cells. Yhm2 transports citrate and oxoglutarate between 
mitochondrial matrix and cytosol. yhm2∆ cells show decreased cytosolic 
NADPH/NADP+ and GSH/GSSG ratios as well as an increased NADPH/NADP+ ratio 
in mitochondria. Our study showed that yhm2∆ cells have decreased level of 
mitochondrial GSH suggesting that it might transport GSH between mitochondria and 
cytosol since its human homologs have been shown to transport cytoplasmic GSH into 





















This chapter includes detailed descriptions of three methods developed during the 
research project. The whole cell GSH measurement is a combination of the temperature 
sensitive strains growth protocol and GSH assay and is modified from Promega 
GSH/GSSG-GloTM Assay. Blocking protocol for Gsh1 protein is provided by Dr. Joseph 
J. Barycki (Department of Biochemistry and the Redox Biology Center, University of 
Nebraska, Lincoln, Nebraska) and modified for Erv1 and Gsh1 proteins. RT-PCR 
protocol was derived from the protocol of Dr. Erin Connolly’s lab (Department of 
Biological Sciences, University of South Carolina, Columbia) and the protocol of Dr. 
Hexin Chen’s lab (Department of Biological Sciences, University of South Carolina, 
Columbia).  
Preparing temperature-sensitive mutant strains for whole cell GSH measurements by 
using the Glo-kit (Promega GSH/GSSG-Glo™ Assay) 
1- Grow fresh cells on SC plates (along with the WT strain) anaerobically for 2 or 3 
days at 24 °C room. 
2- Start the WT strain and temperature-sensitive mutant strains at OD 0.02 in 15 ml 
media in 50-ml tube except erv1-1. Start erv1-1 strain at OD 0.04. Grow them at 
24 °C overnight, shaking at 250 rpm. 
3- Next morning, check OD and make 1:2 or 1:3 dilution with fresh media for 24 °C 
and 37 °C set of cells and grow them for 5 hours. 
4- Five hours later, check OD and transfer 4-5×105 cells into a microcentrifuge tube. 
5- Spin down the pellet at 12k rpm for 20 sec. 
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6- Remove supernatant (media) carefully with the pipette and add 50 µl 1X Lysis 
buffer supplied by the kit. Suspend the cell pellet with lysis buffer several times 
and transfer it to a new microcentrifuge tube. 
7- Add 20 µl glass beads and lyse them in bead-beater machine (cold room) for 4 
min. 
8- Pipette 10 or 20 µl lysate into the well of the 96-well plate (white-solid plates) 
and add 15 or 5 µl sterile water up to 25 µl (Total extract volume should be max 
25 µl). 
9- Add 25 µl total glutathione lysis reagent and shake 5 min in plate reader. 
10- Add 50 µl luciferin generation reagent and incubate 30 min. 
11- Add 100 µl luciferin detection reagent and incubate another 15 min and record the 
luminescence values immediately. 
Total Glutathione Lysis Buffer
µL per reaction reaction number (n) µL per n reaction
Luciferin-NT 1 n 1 × n
Passive lysis B 10 n 10 × n
Water 14 n 14 × n
Luciferin Generation Reagent
µL per reaction reaction number (n) µL per n reaction
DTT(100 mM) 1.25 n 1.25 × n
Glutathione-S-transf 3 n 3 × n
Glutathione Reaction B 45.75 n 45.75 × n







Blocking Conditions for Gsh1 and Erv1 proteins 
1- Transferred blot is soaked in Odyssey blocking buffer  or 5% milk in PBS-T,  
O/N at 4°C 
2- Blot is washed 4 times × 5 min with PBS-T 
3- Primary antibody is diluted to 1/10000 (1µl) in 1% non-fat milk PBS-T for Gsh1 
protein and in 5% non-fat milk PBS-T for Erv1 protein and incubated at RT for 
1h. 
4- Blot is washed 3 times × 15 min with PBS-T 
5- Secondary Ab is diluted to 1/25000 (0.4 µl) in 5% non-fat milk PBS-T and 
incubated at RT for 1 h. 
6- Blot is washed for 10 min × 3 times 
7- Blot is rinsed with PBS buffer and ready to scan. 
RT-PCR Protocol 
Preparation of total RNA by using PureLink® RNA Mini Kit from Invitrogen 
1) Grow fresh cells on an SC plate (along with the WT strain) anaerobically for 2 or 
3 days at 24 °C room. 
2) Start the WT strain and temperature-sensitive mutant strains at OD 0.02 in 15 ml 
media in 50-ml tube except erv1-1. Start erv1-1 strain at OD 0.04. Grow them at 
24 °C overnight, shaking at 250 rpm. 
3) Next morning, check OD and make 1:2 or 1:3 dilution with fresh media for 24 °C 
and 37 °C set of cells and grow them for 5 hours. 
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4) Five hours later, check OD and transfer 4×108 cells to centrifuge tubes and 
centrifuge 500 × g for 5 min at 4°C. Discard the supernatant. 
5) Add up to 100 μL of Zymolase digestion buffer (20 mg/ml) to the yeast cell 
pellet. 
6) Incubate for 30–60 minutes at 24 °C. 
7) Add 200 μL Lysis Buffer prepared with DTT (Prepare fresh amount of lysis 
buffer containing 40 mM DTT for each purification procedure. Add 20 µl of 2 M 
DTT for each 1 mL of lysis buffer. Use RNAse-free water to prepare DTT) 
8) Vortex to mix thoroughly. 
9) Centrifuge at 12,000 × g for 2 minutes at room temperature to pellet cells. 
10) Transfer the supernatant to a clean RNase-free microcentrifuge tube. 
11) Proceed to Binding, Washing, and Elution (Follow the manufacturer’s protocol, 
page 40) 
12) Store your purified RNA at -80°C or proceed to DNase I treatment. 
DNase I treatment (Applied Biosystems Turbo DNase; AM1907) 
1- Mix the following in a 0.5 ml Eppendorf tube and incubate for 30 min at 37°C: 
RNA (10µg total RNA) 
10 × TURBO DNase buffer    2 µl 
TURBO DNase I      1 µl 
Volume up to 20 µl with RNase-free water 
2- Add 2 µl of DNase Inactivation Reagent that has been resuspended and mix well. 
Incubate at room temperature for 5 min 
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3- Spin at 11,000 rpm for 1.5 min. Transfer RNA to a new tube, making sure not to 
transfer any of the DNase Inactivation Reagent. Use directly in cDNA reaction.  
cDNA synthesis using M-MLV RT kit from Invitrogen (28025-013) 
1- Add the following components to nuclease-free microcentrifuge tube (always 
prepare one more than sample’s #) as below; 
3 µl oligo (dT)12-18  
1 µg total RNA (Calculate how many µl is needed for 1 µg RNA in each sample)  
1 µl 10 mM dNTP Mix, 
Volume up to 12 µl with DEPC-treated water  
2- Heat mixture to 65 °C for 5 min and quick chill on ice. Collect the contents of the 
tube by brief centrifugation and add: 
4 µl 5X first-strand buffer 
2 µl 0.1 M DTT 
1 µl RNaseOut Recombinant ribonuclease inhibitor (40 units/ µl)  
3- Mix contents of tube by pipetting up and down gently and incubate at 37 °C for 2 
min 
4- Add 1 µl (200 units) of M-MLV RT and mix by pipetting gently up and down 
5- Incubate tubes at 37 °C for 50 min 
6- Terminate the reaction by incubating tubes at 70 °C for 15 min 
7- Dilute each cDNA to 200 µl by adding 180 µl DEPC water (Total cDNA volume 
is 20 µl) 




Setting up real time reactions 
1. Determine how many reactions you are doing (n) and make up a master mix 
for n+1. Perform reactions in triplicate. Make up SYBR green master mix and 
aliquot it out before touching your cDNA samples. 
2. Include the following controls: Negative controls  
A. No-template control. (use 2 µl DEPC water instead of cDNA) 
B. No-reverse-transcriptase control. 
For SYBR Green Master Mix (1 rxn: 25 µl) 
2× SYBR Green Supermix   12.5 µl 
 Forward primer (10 µM)   1 µl 
 Reverse primer (10 µM)   1 µl 
 DEPC-treated H2O    8.5 µl 
cDNA       2 µl 
3. Aliquot 23 µl of master mix into each well of 96 well plate. 
4. Aliquot 2 µl cDNA/2 µl of H2O or no Reverse Transcriptase controls into 
each well. 
5. Put sealing tape on plate and secure with roller. Tear off the white strips that 
remain on the sides of the tape. Avoid touching the surface of the sealing tape 
with gloved fingers. 
6. Spin plate for 1 min at 800 rpm in centrifuge. 
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Thermal Protocol for RT-PCR 
95 °C    2 min 
95 °C   15 sec 
60 °C   30 sec  
7. Place the plate in the thermal cycler and start the program. 
8. Run the PCR reaction to determine CT values for each sample. (It is important 
to have CT values for the target sequence and the housekeeping gene for each 
sample.) 
9. Calculate the relative quantification of target gene by the 2-ΔΔCT method 
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